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ABSTRACT 
 
Fibroblast growth factor 10 (Fgf10) has been shown to play multiple developmental 
roles and be of high importance for the development of such organs as limbs, lungs and heart. 
However, nothing is known about its putative roles in the development of spinal cord.  
To begin investigation of potential roles of Fgf10 in the spinal cord, its expression 
pattern was examined using tissue from Fgf10-LacZ reporter mice. Fgf10 expression was 
detected through the expression of β-gal, LacZ gene product, either enzymatically with X-gal or 
by immmunostaining. To check the identity of β-gal expressing cells, double-immunostaining 
was performed on sections of Fgf10-LacZ mouse embryos with antibodies against β-
galactosidase and Olig2 (as motor neuron and oligodendrocyte progenitor marker), NeuN and 
TuJ1 (neuronal markers), and Islet 1 and Lhx3 (transcription factors). To investigate the roles of 
Fgf10, Fgf10 knockout mice were used.  Spinal cord sections of wild type and Fgf10 knockout 
embryos were immunostained with antibodies against NeuN, Lhx3, Olig2 (as oligodendrocyte 
marker), Islet1 and TuJ1, and expression patterns were then compared in the sections of the 
same level. 
Fgf10 was detected in the ventral region of the developing mouse spinal cord from E8.5 
to E14.5 and timing of Fgf10 expression correlated with neurogenesis. Fgf10 was shown to be 
expressed in neurons from the early stage of their differentiation until they become mature 
motor neurons. Loss of Fgf10 did not seem to affect motor neuron generation, differentiation 
into particular neuronal subtypes, or their final positioning. However, in Fgf10 knockouts, 
medial motor column (MMC) appeared to be more dispersed and MMC axonal terminals 
seemed to be disordered. 
These results suggest that Fgf10 is involved in the formation and maturation of motor 
neurons, possibly in synapse formation between motor neurons and their target muscles. 
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1. INTRODUCTION 
 
Development of the nervous system is a highly organized and complex process. 
Thousands of neuronal connections build an extremely structured network that makes up the 
functioning nervous system. The development of the vertebrate spinal cord, part of the central 
nervous system, has been well studied (Briscoe and Novitch, 2008). Within the spinal cord, 
specific neuronal subtypes are generated from neural progenitor cells in response to different 
types and concentrations of signals produced from within the neural tube and surrounding 
tissues. These signals regulate the expression of transcription factors, which specify the fate of 
neural progenitors as they differentiate into neurons. In the ventral region of the spinal cord 
there are at least 5 neuronal subtypes: four subtypes of ventral interneurons and one set of motor 
neurons (MN) (Dessaud et al., 2008). Motor neurons project their axons outside the CNS and 
innervate muscles (Eisen, 1999). They can be divided into upper and lower motor neurons, with 
their cell bodies located in the brain and in the spinal cord, respectively. Motor neurons are 
severely affected in motor neuron diseases (MND) (Corcia et al., 2008). 
 MND is a group of neurodegenerative disorders that comprise three main types, which 
affect different groups of motor neurons. Amyotrophic lateral sclerosis (ALS), the most 
common type of MND, affects both upper and lower motor neurons and results in muscle 
wasting, speech and swallowing problems (Carlesi et al., 2011). Progressive muscular atrophy 
(PMA), a less common type of MND, affects lower motor neurons and consequences are less 
severe than in patients with ALS - weakness and atrophy of the body muscles. Primary lateral 
sclerosis, a very rare form of MND, affects upper motor neurons and results in muscle weakness 
and spasticity, but not atrophy (Rowland, 2010). MND is sporadic in 90–95% of cases and 
familial in approximately 5–10%. While studying familial MND cases, mutations in genes that 
code for superoxide dismutase 1 (SOD1), transactive response DNA-binding protein 43 (TDP-
43) and fused in sarcoma/translocated in liposarcoma (FUS/TLS), have been identified and 
linked to MND onset. However, in 90% of the cases, the cause of the disease is still unknown. 
Currently available treatments can only slow down the progression of the disease, but there is 
no cure, as no precise mechanisms that underlie neurodegeneration have been identified (Shaw, 
2005; Traub et al., 2011). 
Degeneration and death of motor neurons in MND diseases leads to outcomes that are 
severe and often lethal, most people with MND die within five years of the onset of symptoms 
(Kanning et al., 2010). In the United Kingdom there are approximately 5000 individuals 
suffering from MND, of which more than a thousand die each year (Shaw, 2005). 
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In the light of this, it is of great importance to study molecular mechanisms of motor 
neuron development. A better knowledge of normal neural development is likely to help 
uncover the mechanisms of neurodegenerative diseases and contribute to the development of 
treatments for the repair of damaged nervous system. Also, knowledge about normal motor 
neuron development can be used to direct differentiation of stem cells in vitro to specific 
neuronal subtypes, which in future could be used to replace damaged nervous tissue.  
 
1.1. Structure of the vertebrate nervous system 
The vertebrate nervous system can be divided into the peripheral and the central 
nervous systems. The central nervous system (CNS) consists of the brain and the spinal cord. 
The peripheral nervous system branches outside from the CNS and is comprised of nerves and 
clusters of neurons called ganglia. 
The CNS is made up of two principle cell types: neurons and glial cells. Neurons, 
generated by radial glial cells, are electrically excitable cells that process and transmit 
information by electrical and chemical signalling. The three basic classes of neurons are sensory 
neurons, motor neurons and interneurons. Sensory neurons process and relay sensory input, 
motor neurons project their axons outside the CNS and synapse muscle fibres and glands, and 
interneurons conduct and interpret impulses from one neuron to another (Slack 2006). 
Glial cells, which include astrocytes, oligodendrocytes and microglia, provide support 
and protection for neurons. In contrast to other glial cells that are derived from neural plate, 
microglia are derived from bone marrow (Chan et al., 2007; Kettenmann et al., 2011). 
Oligodendrocytes form the myelin sheath around axons and support the long-term integrity of 
those axons (Nave, 2010). Astrocytes play a role in glutamate release and removal, which is 
important for neurotransmission, provide nutrients to neurons and remove debris of dead 
neurons (Lee and Pow, 2010). Microglia act as phagocytes and represent immune cells of the 
CNS (Kettenmann et al., 2011). 
 
1.2. Structure of the developing mouse spinal cord 
    The developing mouse spinal cord consists of an inner neuroepithelial layer and a 
central area of grey matter (Leclerc et al., 2011). An outer layer of white matter appears 
postnatally, when mature oligodendrocytes create myelin sheath around axons (Doretto et al., 
2011). The neuroepithelial layer, also called the ventricular zone, lines the lumen of the neural 
tube and functions as a repository of neural stem cells and later gives rise to ependyma (Leclerc 
et al., 2011). The grey matter is mainly comprised of cell bodies of postmitotic neurons. In the 
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grey matter, motor neurons are located ventrally, whereas interneurons and commissural 
neurons, which connect one side of the spinal cord with the other, are primarily found dorsally; 
the sensory neurons are found in the dorsal root ganglia. In addition to the neuronal cells, there 
are specialized cells that form the floor plate in the ventral midline and roof plate in the dorsal 
midline (Fig. 1.1). (Wolpert et al., 2007; Slack, 2006).   
 
Fig. 1.1. Main structures of the developing spinal cord.  
 
1.3. Development of the mouse spinal cord 
Molecular mechanisms that underlie spinal cord development have been well 
characterized (Briscoe and Novitch, 2008). Within the spinal cord, ventricular zone cells are 
organized into distinct progenitor domains in response to signals produced from the neural tube 
and surrounding tissues.  These signals regulate expression of transcription factors, which 
unique combination specifies each progenitor domain that later produces specific neuronal 
subtypes (Dessaud et al., 2008). When neurons become post-mitotic, they migrate outwards 
building concentric layers of cells in the spinal cord (Wolpert et al., 2007). 
 Spinal cord development, for convenience, is usually divided into stages; it begins with 
neural induction and is followed by  rostrocaudal and dorsoventral patterning and a variety of 
secondary patterning events (Bronner-Fraser and Fraser, 1997).  
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1.3.1. Neural induction 
The future CNS appears as the neural plate at embryonic day (E) 7 in the mouse embryo 
as a result of neural induction (Watson et al., 2008). Neural induction is the formation of 
neuroepithelium from the ectoderm in the dorsal region of the embryo in response to signals 
from the underlying mesoderm. The neural ectoderm thickens to form the neural plate, which in 
the following days folds and forms the neural tube (Sanes et al., 2006). The neural tube closes 
by E9.5-10 in the mouse embryo (Watson et al., 2008).   
 
1.3.2. Rostrocaudal patterning 
Rostrocaudal body axis, including the spinal cord, is patterned by Hox genes, members 
of the large family of homeobox genes. In vertebrates, Hox genes form four separate clusters. A 
unique feature of Hox gene expression is that the genes in the clusters are expressed in the same 
spatial and temporal order that they are positioned on the chromosome. The genes lying closer 
to 3` end in the cluster are expressed earlier and more rostrally in the rostrocaudal axis than 
genes lying more 5`(Kmita and Duboule, 2003).  
Hox genes start to be expressed in the mouse embryo at the beginning of gastrulation 
and defined patterns of gene expression are seen in the mesoderm after somite formation and in 
the neural tube after its closure. Hox genes encode transcription factors, which specify 
rostrocaudal body axis into distinct regions and determine subsequent development of a region, 
for example, each somite can be specified by an exclusive pattern of Hox gene expression 
(Wolpert et al., 2007). In addition, Hox gene expression is critical for motor neuron 
differentiation. Members of Hox gene family specify identity of motor neuron columns, identity 
of motor neuron pools and define the pattern of target-muscle connectivity (Dasen et al., 2005).  
The expression of Hox genes within the CNS is under control of several signalling 
molecules including fibroblast growth factors (Fgfs), retinoids, Wnts, and members of the 
transforming growth factor beta (TGF-β) superfamily. Graded Fgf signalling is involved in the 
induction of Hox gene expression at brachial, thoracic and lumbar levels of the spinal cord 
(Dasen et al., 2003). At more rostral levels, Hox genes are regulated by graded retinoic acid 
(RA) signalling, provided by paraxial mesoderm and somites, while at more caudal levels Hox 
genes are controlled by graded TGF-β family member, Gdf11, which acts in concert with high 
levels of Fgf signalling (Fig. 1.2) (Dasen and Jessell, 2009). 
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Fig. 1.2. Rostrocaudal patterning of the neural tube. Hox genes positioned closer to 3` end of 
the chromosome are expressed more rostrally, while genes lying more 5` are expressed more 
caudally. Graded Fgf signalling induces the expression of Hox genes along the rostrocaudal axis 
in the neural tube. Graded retinoic acid (RA) signalling regulates Hox gene expression rostrally, 
while at more caudal levels Hox genes are controlled by graded Gdf11 (Adapted from Dasen 
and Jessell, 2009). 
  
1.3.3. Dorsoventral patterning 
The initial dorsoventral patterning is set up by several extracellular signalling 
molecules; these include Fgf8, Retinoic Acid, Wnts, Bone morphogenetic proteins (BMPs) and 
Sonic Hedgehog (Shh) (Fig. 1.3).  It is commonly acknowledged that BMPs, Wnts and Shh are 
the main players in patterning dorsoventral axis of the spinal cord (Wilson and Maden, 2005). 
BMPs, expressed by the overlying dorsal ectoderm and roof plate cells, specify neuronal fate in 
the dorsal neural tube and, also, inhibit the specification of the ventral neural tube cells. In 
addition to BMPs, Wnt proteins emanating from the dorsal midline have also been found to play 
role in neural progenitor behaviour and neuronal identity (Muroyama et al., 2002; Ulloa and 
Marti, 2010). Sonic Hedgehog, expressed by the notochord and the floor plate, specifies the 
pattern of ventral neurogenesis by providing specific identity and positional information to 
ventral neural progenitor cells (Ericson et al., 1996). 
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Fig. 1.3. Dorsoventral patterning of the neural tube.  The key molecules that pattern 
dorsoventral axis of the neural tube include Sonic Hedgehog (Shh, red), secreted by the 
notochord and floor plate; retinoic acid (RA, green), produced by the somites; BMP and Wnt 
family members (blue), generated by the roof plate (Adapted from Dessaud et al., 2008). 
 
Shh acts in a graded manner: neural progenitors located in more ventral regions of the 
neural tube are exposed to higher Shh concentration, than progenitors located more dorsally. A 
certain concentration of the Shh molecule is needed to generate each progenitor domain, which 
later will differentiate into distinct neuronal subtype. As a result, progenitor domains are 
generated and arranged in a precise spatial order along the dorsoventral axis (Dessaud et al., 
2008). In the ventral spinal cord there are at least five progenitor domains:  four domains of 
ventral interneuron progenitors (p0 – p3) and one domain of motor neuron and oligodendrocyte 
(MN/OL) progenitors (Fig. 1.4). A common progenitor for MN and oligodendrocytes produces 
motor neurons first and  later in development, at E12.5-13, switches to production of 
oligodendrocyte precursors (Li et al., 2011).  
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Fig. 1.4. Generation of distinct neuronal progenitor domains in the ventral spinal cord in 
response to graded Sonic Hedgehog signalling. Graded Shh signalling arranges neural 
progenitors into precise domains (p0-p3, pMN/pOL) along the dorsoventral axis of the spinal 
cord. Neural progenitors located more ventrally are exposed to higher concentration of Shh, 
than progenitors located more dorsally. Shh – Sonic Hedgehog; Fp-Floor plate; p0 – p3 – 
Progenitor domains of ventral interneurons; pMN/pOL – motor neuron and oligodendrocyte 
progenitor domain. 
 
Shh signalling organizes neural progenitors into spatially distinct domains along the 
dorsoventral axis of the neural tube by regulating expression of transcription factors. 
Transcription factors expressed in neural progenitors can be divided into two groups, termed 
class I and II proteins, according to the effect of their regulation by Sonic Hedgehog signalling. 
Shh signalling represses the expression of class I proteins (Pax7, Irx3, Dbx1, Dbx2, and Pax6) 
and induces the expression of class II proteins (Dbx1, Dbx2, Nkx6.1, Olig2, Nkx2.2 and Foxa2) 
(Briscoe et al., 2000). Once expressed, class I and II proteins exhibit cross-repressive 
interactions, which help to define distinct progenitor domains. RA from the paraxial mesoderm 
and Fgf signalling also influence the pattern of transcription factors in progenitor cells. RA 
signalling induces the expression of class I proteins, whereas, Fgf signalling stops dorsoventral 
patterning by blocking both class I and II protein expression (Fig 1.5) (Briscoe and Novitch, 
2008). 
14 
 
 
 
 
Fig. 1.5. Fgf, RA and Shh interaction with class I and II proteins. Fgf signalling suppresses 
expression of class I (Pax7, Irx3, Dbx1, Dbx2, and Pax6) and class II Dbx1, Dbx2, Nkx6.1, 
Olig2, Nkx2.2 and Foxa2) proteins. RA induces expression of class I proteins, whereas Shh 
signalling promotes expression of class II proteins. Once expressed, reciprocal pairs of class I 
and II proteins show cross-repressive interactions to generate discrete progenitor domains 
(Adapted from Briscoe and Novitch, 2008). 
 
Transcription factors produce a unique transcriptional code for each progenitor subtype, 
e.g. motor neuron progenitors are identified by Nkx6.1, Nkx 6.2, Pax6 and Olig2 expression 
(Fig. 1.6). Distinct neuronal subtypes are generated in a precise spatial order from progenitor 
domains at E9-9.5 (Jessell, 2000).  
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Fig. 1.6. A combinatorial expression of transcription factors in the ventral region of the 
spinal cord defines progenitor domains, which later generate distinct neuronal subtypes. 
Each progenitor domain is identified by its unique transcription factor code, which determines 
what neuronal subtype will be generated from a certain progenitor domain, e.g. motor neuron 
progenitors are identified by Nkx6.1, Nkx 6.2, Pax6 and Olig2 expression. Progenitor domains 
p0 - p3 generate different ventral interneuron subtypes (V0-V3), while motor neuron 
progenitors (pMN) produce motor neurons (MN). FP - floor plate (Adapted from Dessaud et al., 
2008).          
 
1.3.4. Motor neuron development in the mouse spinal cord 
Motor neurons are easily identifiable, because they project axons out of the CNS and 
their activity can be recorded through their output – muscle contraction. Therefore, this class of 
neurons has been very well studied and is well characterized (Price and Briscoe, 2004).  
Motor neuron development can be divided into four stages: first, specification and birth 
of motor neurons; second, migration of immature neurons to their final position in the spinal 
cord according to their motor column identity and projection of their axons towards their target 
regions; third, motor pool formation and establishment of synaptic connections and fourth, 
refinement of synaptic connections through the elimination of axon branches and cell death 
(Jessell, 2000, Wolpert et al., 2007).  
The first stage of motor neuron development begins during dorsoventral patterning of 
the spinal cord.   MN progenitor cells, one of the first progenitors to differentiate, are generated 
in a specific domain of ventricular zone in the ventral region of the spinal cord as described 
earlier. Ventral progenitors become specified into motor neuron and oligodendrocyte 
progenitors (MN/OL progenitors), when Olig2 expression is induced in response to continued 
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RA and Shh signaling (Novitch et al., 2003). Olig2 plays an important role in MN and 
oligodendrocyte (OL) generation and differentiation and has been shown to regulate fate switch 
in MN/OL progenitors by reversible phosphorylation on Serine 147. When Olig2 is 
phosphorylated, MN/OL progenitors generate MN, but Olig2 dephosphorylation triggers 
production of OL precursors (OLP) (Li et al., 2011).  Motor neurons share the same population 
of progenitor cells with oligodendrocytes up to the point when Notch signalling is activated 
(Park and Appel, 2003). Notch signalling prevents expression of Ngn2 and maintains MN/OL 
progenitor cells in undifferentiated state until additional signals at E12.5-13, such as Olig2 
dephosphorylation, promote MN/OL progenitors differentiation into OLP. Oligodendrocyte 
precursors subsequently migrate throughout the spinal cord before becoming myelinating 
oligodendrocytes (Cai et al., 2005; Park and Appel, 2003).  
In the absence of Notch signaling, phosphorylated Olig2 promotes expression of Ngn2 
and proneural protein NeuroM that cause MN/OL progenitors to become committed MN 
progenitors and begin to exit the cell cycle. Subsequent downregulation of Olig2 expression 
promotes differentiation of motor neurons (Fig. 1.7) (Briscoe and Novitch, 2008). 
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Fig 1.7. Changes in gene expression in progenitor cells during motor neuron development. 
(i) Neural progenitors expressing Sox1–3 are kept in an undifferentiated state as a result of Fgf 
signalling. (ii) Shh and RA signalling ventralizes neural progenitors by inducing expression of 
Nkx6 and Pax6 transcription factors. (iii) As a result of continued exposure to Shh and RA, 
Olig2 expression is induced in neural progenitors, which now can become both motor neurons 
and oligodendrocytes. (iv) In the presence of Notch signalling, progenitor cells express Ngn2 
and Sox21, become committed motor neuron progenitors and begin to exit the cell cycle.  (v)  
Ongoing RA acid signalling and downregulation of Olig2 expression promotes further 
differentiation of motor neurons. (vi) Activation of Notch signalling prevents the expression of 
Ngn2 in motor neuron/ oligodendrocyte progenitors and maintains these cells in an 
undifferentiated state until additional signals promote differentiation into oligodendrocytes 
(Adapted from Briscoe and Novitch, 2008). 
 
The second stage of motor neuron development begins after motor neurons are born. 
Spinal motor neurons are one of the first neurons to be born. The time when neurons are born is 
defined by the last mitotic division of its progenitor cell (Watson et al., 2008).  In mice, motor 
neurons are born between E 9.5 and E13. First motor neurons are born in the brachial region 
folloed by more caudal regions - thoracic and lumbar regions (Nornes and Carry, 1978). 
MN migrate out of the ventricular zone to settle in an appropriate position, depending 
on to which motor neuron subtype they belong to. MN are specified into subtypes and arranged 
into discrete motor columns depending on the muscles they innervate (Fig 1.8). In mice, MN 
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extend their axons into the periphery as early as E10. The median motor column (MMC) 
innervates axial muscles and is present at all levels of the spinal cord. The preganglionic column 
(PGC) innervates sympathetic ganglia and can be found only at thoracic levels, as well as the 
hypaxial motor column (HMC), that innervates body wall muscles. The lateral motor column 
(LMC) innervates limb muscles and, therefore, is generated only at limb levels of the spinal 
cord. The LMC can be divided further into a medial division (LMCm), that  project axons to 
ventrally derived muscles and a lateral division (LMCl), that project axons to dorsally derived 
muscles (Dasen and Jessell, 2009; Kania et al., 2000).  
Motor neurons are specified into subtypes by rostrocaudal patterning. Hox gene 
expression is critical for motor neuron columnar identity, motor pool identity and initial steps of 
axonogenesis.  Expression of Hox genes defines the position in which distinct motor columns 
are generated. For example, Hox6 expression is restricted to brachial level, where LMC is 
generated, while Hox9 to thoracic level, where PGC and HMC are generated (Dasen and Jessell, 
2009).  
Hox genes function in a combinatorial manner with LIM homeodomain transcription 
factors: Islet 1, Islet 2, Lhx1 and Lhx3 to control motor neuron subtype identity. There are two 
layers of gene regulation to control motor axon projections. One of them is static and specifies 
MN subtypes into columns and pools, while the other layer changes actively and regulates 
motor axon pathfinding (Bonanomi and Pfaff, 2010).  
Specific combinations of the LIM homeodomain transcription factors, which are static, 
identify motor column subtype: Islet 1, Islet 2 and Lhx3 are molecular markers of the MMC 
column; Islet 1 and Islet 2 define the HMC column; the combination of Islet 2 and Lhx1 identify 
the LMCl; Islet 1 and Islet 2 label the LMCm; and Islet 1 expression defines the PGC column 
(Fig. 1.8) (Dasen et al., 2003; Tsuchida et al., 1994). 
Dynamic regulation of LIM homeodomain transcription factor expression guides the 
projection of motor neuron axons to specific muscles. For example, in MMC neurons, Lhx3 
controls the expression of fibroblast growth factor receptor 1 (FgfR1), which makes them 
sensitive to dermomyotome-derived FGFs that act as strong chemoattractants for MMC axons 
(Shirasaki et al., 2006). In LMCl neurons, Lim1 has been linked to the control of EphA4 
receptor, and in LMCm neurons Isl1 has been linked to EphB1receptor (Kania and Jessell, 
2003; Luria et al., 2008). Also, Lhx3 expression has been shown to be necessary for MN axons 
to exit spinal cord ventrally. Initially, when MN are born, Lhx3 is expressed in all of them for a 
short period of time, and then is rapidly downregulated in all except the MMC neurons (Sharma 
et al., 1998). Shortly after motor axons exit the neural tube they select their innervation targets 
(Bonanomi and Pfaff, 2010). 
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Fig. 1.8. Motor neuron columnar organization in the spinal cord.  Motor neurons are 
segregated into longitudinal motor columns along the rostrocaudal axis of the spinal cord 
according to their innervation targets. The medial motor column (MMC, blue) neurons are 
generated at all rostrocaudal levels of the spinal cord and project axons to the axial muscles 
(dermomytome, dm). The lateral motor column (LMC) spanning brachial and lumbar levels of 
the spinal cord is further divided into lateral (LMCl, green) and medial (LMCm, purple) 
divisions, which project axons to muscles of dorsal (dlb) and ventral limb bud (vlb) 
respectively. Preganglionic motor column (PGC, orange) neurons, which innervate sympathetic 
ganglia (sg), and hypaxial motor column (HMC, red) neurons, which innervate body wall 
muscles (bw), are located at thoracic levels. A unique combination of LIM homeodomain 
transcription factors identifies motor column subtype: Islet 1, Islet 2 and Lhx3 characterize 
MMC column; Islet 1 and Islet 2 are specific for the HMC column; the combination of Islet 2 
and Lhx1 identifies the LMCl; Islet 1 and Islet 2 label the LMCm and Islet 1 expression defines 
the PGC column. C - caudal. R – rostral (Adapted from Bonanomi and Pfaff, 2010). 
 
The third stage starts at about E11.5-12 when LMC axons begin to sort into medial and 
lateral divisions and into motor pools. A motor pool is a group of motor neurons that innervate 
the same muscle. The existence of a great variety of muscle groups in the limbs demands an 
equivalent diversity of motor pools (Dasen et al., 2005). Motor pool identity is also controlled 
by Hox genes (Dasen and Jessell, 2009).  
Once MN axons have arrived at their target, the formation of synapses begins. Before 
an axon terminal has approached, acetylcholine receptors become concentrated in the central 
region of the muscle fibre. When the motor axon arrives, it secretes Agrin into the basal lamina, 
which induces clustering of acetylcholine receptors and specialization of muscle cell surface. 
Signals from the muscle in turn promote differentiation of the pre-synaptic zone on the axon 
terminal and align it with the post-synaptic area. Process of MN axon projection and synapse 
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formation is very accurate, although, some pathfinding errors take place and they are eliminated 
by editing during the fourth stage (Colon-Ramos, 2009).  
The fourth stage begins at about E12, shortly after MN axons reach their targets and 
includes refinement of synaptic connections through the elimination of axon branches and cell 
death (Yamamoto and Henderson, 1999). Once a motor neuron axon has established a contact 
with a muscle cell, it can activate the muscle, and this is followed by the death of the other MN 
that were navigating to the same muscle cell. Nevertheless, some muscle fibres become 
innervated by several axon terminals and then most connections are eliminated by programmed 
cell death, until each muscle fibre is innervated by one axon (Wolpert et al., 2007). 
 
1.4. Fibroblast growth factor signalling system 
 
14.1. Fibroblast growth factors 
The mammalian Fibroblast growth factor (Fgf) signalling system consists of Fgfs that 
act as extracellular ligands that bind to and activate four receptor tyrosine kinases termed 
FgfR1, FgfR2, FgfR3 and FgfR4 (Eswarakumar et al., 2005). Fibroblast growth factors 
comprise a large family of signalling molecules that have been found both in invertebrates and 
vertebrates. The Fgf family consists of  22 members in mouse (Fgf 1-18, 20-23) and in human 
(FGF 1-14, 16-23) (Ornitz and Itoh, 2001). 
The molecular weight of vertebrate Fgf`s varies from 17 to 34 kDa. Gene structure and 
amino-acid sequence of Fgfs are highly preserved between vertebrates and all the members of 
the family share a conserved 120- amino acid residue core with 16% to 65% amino acid 
similarity (Eswarakumar et al., 2005). 
Vertebrate Fgfs can be classified into seven subfamilies by phylogenetic analysis: Fgf1 
(1,2), Fgf4 (4,5,6), Fgf7 (3,7,10,22), Fgf8 (8,17,18), Fgf9 (9,16,20), iFgfs (11,12,13,14), and 
hFgfs (15, 21, 23) (Fig 1.9). Members of a subfamily share high sequence similarity, similar 
receptor-binding properties and some overlapping sites of expression. For example within Fgf7 
subfamily, Fgf10 has 60% amino acid sequence identity with Fgf7 and Fgf3, and members of 
the Fgf8 subfamily (Fgf8, Fgf17, and Fgf18) have 70-80% amino acid sequence identity 
(Maruoka et al., 1998; Yamasaki et al., 1996). 
 Fgf family proteins are expressed in many tissues, but the patterns and timing of 
expression are different. Some Fgfs are expressed only in embryonic tissues (Fgf3, 4, 8, and 
17), whereas others are expressed in embryonic and adult tissues. Patterns of Fgfs expression 
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suggest that they play vital roles in organism development and repair. During embryonic 
development Fgfs have diverse roles in regulating cell proliferation, migration and 
differentiation (Ornitz and Itoh, 2001). For example, Fgf10 has been shown to promote 
proliferation of epithelial progenitor cells during pancreatic organogenesis (Bhushan et al., 
2001).  Fgf2 and Fgf4 in vitro stimulate migration of myogenic cells in mouse embryonic limbs 
(Webb et al., 1997). Fgf18 is required for cell proliferation and differentiation during 
osteogenesis (Ohbayashi et al., 2002). In the adult, Fgfs act as homeostatic factors and play 
significant roles in cell differentiation, tissue repair and wound healing (Eswarakumar et al., 
2005; Ornitz and Itoh, 2001). Fgf7 and Fgf10 have been shown to play an important role in skin 
wound healing (Komi-Kuramochi et al., 2005). 
 
 
 
 
Fig. 1.9. Phylogenic tree of mouse Fgf gene family. Mouse Fgf gene family can be divided 
into seven subfamilies containing two to four members each. Branch lengths are proportional to 
the evolutionary distance between each gene (Adapted from Itoh and Ornitz, 2008). 
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1.4.2. Fibroblast growth factor receptors 
In human and mice there are four FgfR genes, FgfR1 – FgfR4, that encode four FgfR 
tyrosine kinase receptors FgfR1-4.  FgfRs are comprised of an extracelullar ligand binding 
domain that consists of three immunoglobulin-like (Ig-like) domains (I, II, III), a 
transmembrane domain and a cytoplasmic tyrosin kinase domain (Jaye et al., 1992).  
A significant characteristic of the FgfR family is a variety of isoforms that are generated 
by alternative mRNA splicing of FgfR 1, 2 and 3, but not FgfR4 transcripts. Alternative splicing 
of exons 8 and 9 generates either IIIb or IIIc isoforms of FgfR: splicing of exons 7 and 8 
generates FgfR-IIIb isoform, while combination of exons 7 and 9 generates the FgfR-IIIc 
isoform (Fig. 1.10) (Eswarakumar et al., 2005).  
 
 
 
Fig. 1.10. Structure of FgfR isoforms generated by alternative splicing of FgfR transcripts. 
FgfR consists of three immunoglobulin-like (Ig-like) domains (I, II, III), a transmembrane 
domain (TM) and a protein tyrosin kinase domain (PTK). SP - signal peptide. The b and c 
isoforms of FgfR are produced in the result of alternative splicing of exons 8 and 9. 
Combination of exons 7 and 8 generates FgfR-IIIb isoform, while combination of exons 8 and 9 
generates the FgfR-IIIc isoform. (Adapted from Eswarakumar et al., 2005). 
 
Consequently, seven FgfR proteins (Fgfrs 1IIIb, 1IIIc, 2IIIb, 2IIIc, 3IIIb, 3IIIc, and 4) 
are generated from four FgfR genes. Difference between the isoforms is found in the third Ig-
like domain and changes ligand-binding specificity. For example FgfR2-IIIb isoform binds 
Fgf7, Fgf10 and Fgf22, but not Fgf4 or Fgf6 that activate FgfR2-IIIc. The specificity of these 
isoforms towards various Fgf ligands is summarized in the table below (Table 1.1) 
(Eswarakumar et al., 2005).  
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Fgfr isoform Ligand specifisity 
FgfR1-IIIb Fgf 1, -2, -3 and -10 
FgfR1-IIIc Fgf 1, -2, -4, -5 and -6 
FgfR2-IIIb Fgf 1, -3, -7, -10 and -22 
FgfR2-IIIc Fgf 1, -2, -4, -6, -9, -17 
FgfR3-IIIb Fgf 1 and -9 
FgfR3-IIIc Fgf 1, -2, -4, -8, -9, -17, -
FgfR4 Fgf 1, -2, -4, -6, -8, -9, -
 
Table 1.1. Ligand specificities of Fgfr isoforms  
 
1.4.3. Fgf signalling through FgfRs  
Fgf family contains 22 members, however, only 18 of them act through FgfRs. 
Members of iFgf subfamily (Fgf11-14) do not mediate their response by activating FgfRs and 
are called homologous factors (Itoh and Ornitz, 2008; Smallwood et al., 1996). iFgfs lack signal 
sequences and are considered to have an intracellular role (Itoh and Ornitz, 2008). Fgf1 and 
Fgf2, also, lack signal sequences and hence are not secreted, though, they can be found on the 
cell surface and extracellular matrix (Ornitz and Itoh, 2001).  
Secreted Fgfs act as signal molecules that bind and activate FgfRs. FgfRs get activated 
when Fgf ligand, bound to heparan sulfate proteoglycans (HSPG), binds to the receptor causing 
its dimerization. HSPG act as a low-affinity receptor that does not transmit signal, but functions 
as an accessory molecule and has been shown to increase affinity and half-life of the Fgf-FgfR 
complex (Eswarakumar et al., 2005; Ornitz and Itoh, 2001). Also, Fgf interaction with HSPG 
stabilizes Fgfs to thermal denaturation and proteolysis (Ornitz and Itoh, 2001). 
FgfRs mediate their signalling by recruiting specific proteins that bind to tyrosine auto-
phosphorylation sites on the activated receptor and by using docking proteins that become 
tyrosine phosphorylated in response to Fgf-stimulation. Fgf-stimulation of docking proteins of 
the FRS2 family results in activation of the Ras/ mitogen - activated protein (MAP) kinase and 
phosphatidylinositol - 3 (PI-3) kinase signalling pathways (Eswarakumar et al., 2005; Kouhara 
et al., 1997) 
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1.5. Fgf signalling in the developing mouse spinal cord  
 
1.5.1. Fgfs and FgfRs involved in the development of mouse spinal cord 
Fgf signalling plays an important role in the development of the CNS. There have been 
multiple studies on Fgf expression during brain development, while Fgf contribution to spinal 
cord development still has to be described in more details (Ford-Perriss et al., 2001).   
Three out of four FgfR receptors have been detected in the developing mouse spinal 
cord by Shirasaki in 2006, however, receptor isoforms have not been specified. FgfR1 
expression localizes in the ventral horns of the spinal cord, while FgfR2 and FgfR3 are 
expressed in the ventricular zone (Shirasaki et al., 2006). Later, Fon Tacer showed in 2010 that 
FgfR-IIIc isoform is predominant in adult mouse CNS, including the spinal cord (Fon Tacer et 
al., 2010). 
Fgfs are expressed in the spinal cord from the very beginning of its formation. Fgfs are 
required for the neural induction and generation of neural tissue (Wilson and Maden, 2005). A 
gradient of Fgf8, in particular, is necessary for the induction of Hox genes that are essential for 
patterning the rostrocaudal axis of the neural tube (Crossley and Martin, 1995).   
A number of Fgfs have been shown to be expressed in the developing spinal cord e.g. 
Fgf1, Fgf2, Fgf9 and Fgf15 (Colvin et al., 1999; Ford-Perriss et al., 2001). Mouse Fgf2 mRNA 
has been shown to be expressed in the neural tube, including the ventricular zone, and within 
dorsal root ganglia (DRG) starting from E10, when neural crest precursors are proliferating 
within the DRG and consequently might play a role in the proliferation of neuronal precursors 
(Ford-Perriss et al., 2001; Murphy et al., 1994). 
Fgf9 is strongly expressed in the developing motor neurons from E10 to E14 and its 
expression pattern suggests a role in the development and maintenance of motor neurons and a 
possible role in skeletal muscle innervation (Colvin et al., 1999; Garces et al., 2000).  
Fgf15 is expressed in the dorsal region of the developing spinal cord from E8 to E14 
and may play an important role in regulating cell division and patterning within the embryonic 
spinal cord (Ford-Perriss et al., 2001; McWhirter et al., 1997).  
Recently, Fgf10 expression has been detected in the developing mouse spinal cord, 
which implicates it in mouse spinal cord development (unpublished data of M.K. Hajihosseini).  
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1.5.2. Fgf10 expression in the developing mouse spinal cord 
Fgf10 encoding cDNA was originally isolated from rat embryos in 1996 (Yamasaki et 
al., 1996). It was soon followed by isolation of mouse Fgf10 cDNA, which encoded a secreted 
protein of 209 amino acids (Tagashira et al., 1997).  
Fgf10 has been shown to play diverse roles in the development of many different 
tissues. So far, Fgf10 has been shown to play critical roles in limb and lung development and an 
important role in heart development (Abler et al., 2009; Kelly et al., 2001; Min et al., 1998; 
Vega-Hernandez et al., 2011; Zakany et al., 2007). Also, Fgf10 is essential for the development 
of pancreas, white adipose tissue, mammary glands, eyelids, intestine, liver  and brain (Berg et 
al., 2007; Bhushan et al., 2001; Konishi et al., 2006; Mailleux et al., 2002; Nyeng et al., 2011; 
Sahara and O'Leary, 2009; Tao et al., 2005). At the meantime, studies to determine Fgf10 role 
in adult animals are limited, because Fgf10 knockout mice die at birth (Min et al., 1998). 
Fgf10 expression has, also, been detected in the spinal cord of juvenile and adult mice, 
aged 4 and 56 days, respectively (Allen Institute for Brain Science database) (Fig. 1.11). 
Despite the fact that Fgf10 expression has been shown in the mouse spinal cord, at the moment, 
there are no publications related to possible Fgf10 roles in that region.  
 
 
 
Fig 1.11. In situ hybridisation of Fgf10 in 4 days (A) and 56 days (B) old mouse spinal 
cord. (A) Transverse section of the spinal cord at thoracic level of 4 days old mouse; Fgf10 is 
expressed in the ventral horns of the spinal cord. (B) Transverse section of the spinal cord at 
thoracic level of 56 days old mouse; Fgf10 expressing cells are scattered across the spinal cord. 
 
Recently, Fgf10 expression has been detected by in situ hybridisation in the spinal cord 
of E12.5 mouse embryo and it is the first evidence of Fgf10 expression in the developing mouse 
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spinal cord (unpublished data of M. K. Hajihosseini). At E12.5, Fgf10 is mainly localized in the 
ventral horns of the spinal cord, in the area where motor neurons normally reside (Fig. 1.12).  
 
 
 
Fig. 1.12.  In situ hybridisation of Fgf10 in the E12.5 developing mouse spinal cord. Please 
note that the section has been torn dorsally. Fgf10 expression is shown in red and is mainly 
localized in the ventral horns of the spinal cord (unpublished data of M.K. Hajihosseini). 
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1.6. Aims 
Molecular pathways of spinal motor neuron development are among the most 
characterized ones.  However our knowledge about relevant pathways of MN organization and 
differentiation is still incomplete. Recently, studies have shown that a member of the fibroblast 
growth factor family- Fibroblast Growth Factor 10 (Fgf10) is expressed in the ventral part of 
the developing mouse spinal cord, in the region where motor neuron bodies usually are located 
(unpublished results of M. K. Hajihosseini).  
During embryonic development, Fgf10 is widely expressed in various tissues of the 
mouse organism, and is known to play a key role in the organogenesis of various organs, 
including lungs, pancreas, mammary glands, limbs and brain (Bellusci et al., 1997; Bhushan et 
al., 2001; Mailleux et al., 2002; Min et al., 1998; Sahara and O'Leary, 2009). Until now, Fgf10 
expression in the developing spinal cord has not been reported, and nothing is known about its 
possible function in that region. 
In this report I examine the Fgf10 expression pattern and investigate its role in the 
developing mouse spinal cord. Preliminary studies have shown that the region of Fgf10 
expression correlates with where motor neurons normally reside, which lead us to hypothesize 
that Fgf10 may be involved in the development of spinal motor neurons.  
Hypothesis: Fgf10 is involved in the development of motor neurons 
Aims: To investigate the hypothesis, three aims were set up: 
1) To determine the timing and pattern of Fgf10 expression in the 
developing mouse spinal cord, across different embryonic ages. 
2) To determine what cell types express Fgf10; are they motor neurons? 
3)  To investigate how loss of Fgf10 affects the development of motor 
neurons and other cell types in the spinal cord. 
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2. MATERIALS AND METHODS 
 
2.1. Transgenic mouse lines  
All mouse lines were bred on a mixed genetic background according to the local 
regulations for transgenic breeding. 
 
2.1.1. Fgf10LacZ/+ mice 
Fgf10LacZ/+ (Fgf10-LacZ) transgenic mouse line was originally created by Kelly in 2001 
(Kelly et al., 2001).  Fgf10-LacZ mice carry a heterozygous transgene insertion encoding 
nuclear LacZ (nLacZ) downstream of the Fgf10 promoter and are acknowledged to be a reliable 
reporter of Fgf10 expression (Hajihosseini et al., 2008; Kelly et al., 2001). The genomic 
structure of the Fgf10-LacZ allele is shown in Figure 2.1.  LacZ gene encodes an enzyme β-
galactosidase (β-gal), which in the presence of a substrate X-gal produces a blue precipitate. 
Therefore, Fgf10 expression can be traced either by using anti- β-gal antibodies or by treating 
tissue with X-gal solution.  
 
 
 
Fig. 2.1. Schematic diagram of the genomic structure of wild type (top) and Fgf10-LacZ 
(bottom) allele. The nuclear LacZ (nLacZ) transgene is located 114 bp upstream of the Fgf10 
gene and is under the control of the Fgf10 promoter. LacZ gene encodes an enzyme β-
galactosidase (β-gal), which converts substrate X-gal into a blue precipitate (Adapted from 
Kelly et al., 2001). 
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2.1.2. Fgf10 -/- mice  
Fgf10-/- (Fgf10 knockout) allele was originally generated by Min in 1998 (Min et al., 
1998). A PGK-neo (NEO) cassette was inserted into the region of the first exon, which encodes 
the translation start site and the putative signal peptide. The genomic structure of the Fgf10 
knockout allele is shown in Figure 2.2. This strategy eliminated the translation initiation codon 
(ATG) and the signal peptide, and inserted multiple stop codons in-frame, as a result, no Fgf10 
protein was produced. Homozygous Fgf10 knockout mouse embryos (Fgf10 -/-) are smaller than 
wild type, they do not develop limbs and die at birth due to the absence of lungs (Fig. 2.3). 
 
 
Fig. 2.2. Schematic diagram of the genomic structure of wild type (top) and Fgf10 
knockout (bottom) allele. A neomycin (NEO) cassette is inserted into the first axon of Fgf10 
gene that stops it from being transcribed (Adapted from Min et al., 1998). 
 
 
 
Fig. 2.3. Wild type (A) and Fgf10 knockout (B) embryos at E18.5. Fgf10 knockout embryos 
lack limbs and lungs, and appear to be smaller in size compared to wild type (Adapted from 
Min et al., 1998). 
 
2.1.3. FgfR2-IIIc +/∆ mice 
FgfR2-IIIc +/∆ (FgfR2-IIIc hemizygotes) mice were originally generated by Hajihosseini 
in 2001 through a heterozygous LoxP-Cre mediated excision of “floxed” (flanked by LoxP 
sequences) exon 9, specific for FgfR2-IIIc isoform (Hajihosseini et al., 2001). For the genomic 
structure of the FgfR2-IIIc deficient allele, please, see Figure 2.4. Absence of one copy of 
FgfR2-IIIc in mice results in a gain-of-function effect due to a splicing switch in the FgfR2-IIIc 
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deficient allele.  FgfR2-IIIc +/∆ mice show illegitimate expression of FgfR2-IIIb isoform in 
mesenchymal and neural tissues along with FgfR2-IIIc. That makes the relevant tissues 
responsive not only to FgfR2-IIIc specific Fgfs (Fgf1, -2, -4, -6 and -9), but also to FgfR2-IIIb 
specific Fgfs (Fgf3, -7, -10 and -22). This leads to certain abnormalities, such as bone and 
visceral defects, which are reminiscent of Apert syndrome (Hajihosseini et al., 2001).   
 
 
 
Figure 2.4. Structure of Fgf receptor and genomic structure of FgfR2 locus in FgfR2-IIIc 
hemizygote mouse.  (A) Schematic structure of FgfR2, which consists of an extracellular 
domain, containing three Ig-like loops, a transmembrane (TM) segment, and an intracellular 
tyrosine kinase domain. In the result of an alternative splicing of exons, encoding third Ig-like 
loop, either IIIb or IIIc receptor isoforms are generated. (B) Schematic diagram of the genomic 
structure of wild type (top) allele and FgfR2 allele with excised exon 9 (bottom), that results in 
FgfR2-IIIc deficiency. Mice deficient in one copy of FgfR2-IIIc experience a gain-of-function 
mutation (Adapted from Hajihosseini et al., 2001). 
 
2.2. Embryo isolation and genotyping 
Animals were sacrificed by CO2 asphyxiation, embryos of the relevant age (table 2.1) 
were isolated and their yolk sacs were harvested for genomic DNA isolation. Genomic DNA 
was isolated by digestion by Proteinase K overnight at 55°C, followed by sample centrifugation 
to remove the digested tissue.  Genomic DNA was then precipitated with isopropanol and 
resuspended in 30% TE buffer in ddH20. All embryos were genotyped by PCR using genomic 
DNA from embryo’s yolk sacs. Embryos were genotyped by PCR using the Expand Long 
Template PCR System (Roche), according to manufacturer’s instructions. For the list of primers 
used, please see table 2.2.  
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   Genotype 
Age 
Wild type Fgf10LacZ/+ Fgf10 -/- FgfR2-IIIc +/∆ 
E8.5 - 2 - - 
E9.5 3 5 - - 
E10.5 1 - 1 - 
E11.5 - 7 - - 
E12.5 3 10 - 1 
E14.5 1 1 1 - 
E15.5 - 1 - - 
 
Table 2.1. Age, genotype and number of the embryos used in this study. 
 
Allele Primers 
Expected 
product/s 
(kbp) 
Fgf10lacZ 
(Forward) GCA TCG AGC TGG GTA ATA AGC GTT GGC AAT 
LacZ+:0.8 
(Reverse) GAC ACC GAC ACA ACT GGT AAT GGT AGC GAC 
(Forward) CGA GTG GAG CAT GTA CTT CCG TGT CCT GAA Wild type: 
0.5 (Reverse) TCC CTA CCC AGT CAC AGT CAC AGC TGC ATA 
Fgf10 
knockout 
(Forward) CAC CAA AGA ACG GAG CCG GTTG  
Knockout: 
0.9 
(Reverse) ACT CTT TGG CCT CTA TCT AG 
FgfR2-
IIIc +/∆ 
 
(Forward) CAC TCT ATC AAG GCA TGC AGC AAGC 
Floxed/+: 
2.0 
Wild type: 
1.9 
FgfR2-IIIc 
+/∆ 
 0.5 
(Reverse) CTG CGG CCG CCA GTC TGC CTG GCT CAC TGT CCT 
GCC 
 
Table 2.2.  Primers used for genotyping (5’-3’). 
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2.3. Tissue fixation 
Embryos to be immunostained, were fixed with 4% paraformaldehide (PFA) at room 
temperature (RT) at least for 30 mins and then washed in PBS twice for 10 mins. Embryos to be 
treated with X-gal were fixed with 0.5% Gluteraldehyde and 2% PFA made in phosphate 
buffered saline (PBS), and then rinsed in PBS twice for 10 mins. 
 
2.4. Dehydration and rehydration of the tissue 
After fixation, embryos were dehydrated by being washed in PBS twice for 10 min, 
followed by washing in ascending series of ethanol, 30% and  50% ethanol made in PBS, 70% 
and 90% ethanol, made in dH2O, each step being 15 to 30 min long, depending on the age of the 
embryos. Dehydrated embryos were stored in absolute ethanol at +4°C until use. Before 
sectioning, embryos were rehydrated to PBS by being washed in descending series of ethanol 
(90%, 70%, 50% and 30% ethanol), followed by washes in PBS, twice for 10 min.  
 
2.5. X-gal staining  
X-gal staining was performed to identify the presence of β-galactosidase. After fixation, 
the embryos were incubated at 37°C in pre-warmed 0.5 µg/ml X-gal, diluted in X-gal staining 
buffer (2 mM MgCl2, 5 mM K4Fe(CN)6 and 5 mM K3Fe(CN)6 in PBS) for 2-4 hrs or overnight 
(o/n), until a blue precipitate was produced. The reaction was stopped by replacement of X-gal 
solution with PBS. The embryos were washed in PBS twice for 10 mins at RT on a rocking 
platform, followed by postfixation with 4% PFA for 15-30 mins and switched back to PBS by a 
10 min wash.  The embryos were then dehydrated and rehydrated in ascending and desceding 
series of ethanol respectively and sectioned on the vibratome. 
 
2.6. Tissue blocking 
Rehydrated embryos were immersed in molten solution of 3% agar (made in dH2O) and 
placed into the water bath at +80°C for 15-20 min. Tubes containing embryos were agitated 
every 5 minutes for better agar penetration. The embryos and agar were then poured into tin-foil 
boats, the embryos were orientated into desirable position and the agar was allowed to set. Agar 
blocks were kept for 1 hour at RT to allow agar to set and then were stored at +4 °C overnight.    
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2.7. Tissue sectioning on the vibratome 
The tissue was sectioned using a vibratome (microtome with vibrating blade) (Leica 
VT1000 S). Before sectioning, the foil was removed and excess agar was trimmed with a blade 
from the agar block, leaving a margin of about 0.5 cm around the embryo. The agar block was 
mounted onto the specimen disc using superglue, which was then inserted into the buffer tray. 
The buffer tray was filled with +4°C PBS, the blade was aligned and then sections were cut at 
60-80 µm width. Sections were collected using a fine paint brush, transferred to wells of 48-well 
plates filled with PBS and stored at +4°C until used. 
 
2.8. Immunostaining of vibratome sections  
Immunostaining of vibratome sections was carried out in 3ml glass vials. To block non-
specific binding sites, the sections were incubated at least for 2 hours at RT on a rocking 
platform, with solution containing 20% normal goat serum (NGS) and 1% Triton X100, diluted 
in PBS. After blocking, the sections were incubated at 4°C on a rocking platform with primary 
antibody diluted in a solution containing 0.2% NGS and 0.1% Triton X100, made in PBS (Table 
2.3).  
The next day, the sections were washed five times at RT on a rocking platform, each 
wash being an hour long, in 0.2% NGS and 0.1% Triron X100, prepared in PBS. The sections 
were then incubated o/n at 4°C on a rocking platform with the relevant secondary antibodies 
diluted in a solution containing 0.2% NGS and 0.5% NP-40, made in PBS (Table 2.4).  
After incubation with a secondary antibody, the sections were washed six times in PBS 
at RT on a rocking platform, each wash being 30 mins long. During the last five minutes of the 
last wash sections were counterstained with Hoechst (1:1000), to visualize cell nuclei. The 
sections were then switched back to PBS by 10 mins wash and mounted onto the slides with an 
adhesive surface using Vectashield mounting medium (Vector Labs). Cover slips were put onto 
the slides and immobilized with clear nail varnish. Slides were stored at 4°C. 
If a biotinylated secondary antibody was used the day before, the sections were washed 
five times at RT on a rocking platform, each wash being an hour long, in 0.2% NGS and 0.1% 
Triton X100, diltuted in PBS. The sections were then incubated at 4°C on a rocking platform 
with tertiary antibody diluted in 0.2% NGS and 0.5% NP-40, prepared in PBS (Table 2.5). The 
next day, the sections were washed in PBS, stained with Hoescht and mounted. 
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2.9. Immunostaining of tissue previously treated with X-gal 
Before blocking non-specific binding sites, the sections were bleached for 1.5 hours at 
RT on a rocking platform, in a solution of 6% hydrogen peroxide, diluted from 30% stock 
solution and made in PBS. Then non-specific binding sites were blocked, sections were 
incubated  with primary antibody and washed the next day as described above. The sections 
were then incubated o/n at 4°C on a rocking platform with a Goat anti-Rabbit Horse Radish 
Peroxidase (HRP) secondary antibody (1:1000) diluted in 0.2% NGS and 0.1% Triton X100, in 
PBS. The next day, the sections were washed 6 x 1 h in PBS, then 3 x 20 mins in 0.05M Tris-
HCl buffer (0.1 M tris base, 0.1M HCl, ddH2O, pH 8). Tris buffer was then replaced with 
chilled diaminobenzidine (DAB) staining solution (dH2O, H2O2, Tris buffer, DAB). DAB 
staining was carried out and monitored under a dissecting microscope. After the stain became 
visible in the period from 30 sec to 2 mins, the reaction was stopped by replacing DAB staining 
solution with PBS. The sections were mounted as described above. All antibodies used in this 
study have been summarized in tables 2.3, 2.4 and 2.5. 
 
Primary antibodies 
Antibody (anti-) Raised 
in 
Dilution Cell type detected Source 
β-galactosidase 
 
Rabbit 1:1000 product of bacterial gene, 
LacZ 
Millipore (Chemicon) 
β-galactosidase 
 
Mouse 1:50-1:300 
product of bacterial gene, 
LacZ 
 
Sigma, Abcam, Cell 
Signalling, DSHB 
BLBP Rabbit 1:200 Radial glial cell marker 
 
Abcam 
GFAP Rabbit 1:1000 Astrocytes Chemicon (Millipore) 
GFAP Mouse 1:800 Astrocytes Chemicon (Millipore) 
Islet 1 Mouse 1:100 Differentiated motor neurons (except LMCl neurons) DSHB 
Lhx3 Rabbit 1:400 MMC neurons and V2 
interneurons 
Abcam 
Nestin Mouse 1:100 Neural precursors DSHB 
NeuN Mouse 1:1500 Postmitotic neurons Chemicon (Millipore) 
Olig2 Rabbit 1:500 Oligo precursors Chemicon (Millipore) 
TuJ1 Mouse 1:1500 Differentiated neurons Chemicon (Millipore) 
 
Table 2.3. Primary antibodies used for immunostaining. 
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Secondary antibodies 
Antibody 
(anti-) 
Raise
d in 
Conj
ugate 
Diluti
on 
Source 
mouse 
 
Goat Alexa 488 1:1000 Invitrogen 
mouse 
 
Goat Alexa 568 1:1000 Invitrogen 
rabbit Goat Alexa 488 1:1000 Invitrogen 
rabbit Goat Alexa 568 1:1000 Invitrogen 
mouse IgG Goat Biotinylated 1:300 Jackson 
Immunoresearch 
mouse IgG1 Goat Biotinylated 1:300 Jackson 
Immunoresearch 
rabbit Goat HRP 1:1000 Vector Laboratories 
 
Table 2.4. Secondary antibodies used for immunostaining. 
 
Tertiary reagents 
Antibody (anti-) Dilution Source 
Streptavidin-Texas-red 1:800 Jackson Immunoresearch 
 
Table 2.5. Tertiary antibodies used for immunostaining. 
 
2.10. Microscopy 
Sections immunostained with fluorescent antibodies were imaged on a Zeiss 
Axioimager M2 microscope with an Apotome attachment.  Sections immunostained with HRP 
antibody and/or stained with X-gal were imaged on an upright microscope using differential 
interference contrast (DIC). Images were acquired using Axiovision 4.8 software and processed 
using Adobe Photoshop. Cells in the sections were counted using Fiji software.  
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3. RESULTS 
 
3.1 Fgf10 is expressed in the ventral horns of the developing mouse 
spinal cord during neurogenesis 
Previous unpublished studies from our laboratory have shown Fgf10 expression in the 
developing mouse spinal cord at E12.5 by in situ hybridisation (Fig. 1.12). The first aim of my 
project was to examine the timing and pattern of Fgf10 expression in the developing mouse 
spinal cord across different ages.  
Presently, commercially-available anti-Fgf10 antibodies do not work well in 
immunohistochemical reactions, hence, Fgf10-LacZ mouse embryos were used.  This mouse 
line carries a heterozygous LacZ transgene insertion downstream of Fgf10 promoter (Kelly et 
al., 2001). LacZ gene codes for an enzyme β-galactosidase (β-gal), which converts substrate X-
gal into a blue precipitate. In this mouse, β-gal has been shown to be a faithful reporter of Fgf10 
expression (Kelly et al., 2001; Hajihosseini et al. 2008). However, it is not known how stable β-
gal is, therefore, it might be detected not only in Fgf10 expressing cells, but also, in their 
descendants. 
Embryos ranging from E8.5 to E15.5 were isolated from Fgf10-LacZ mice, treated with 
X-gal and LacZ positive embryos were sectioned on the vibratome in a transverse plane. 
Sections were mounted onto slides in the anatomical succession and imaged on an upright 
microscope with DIC filter.  
It was found that β-gal positive (β-gal +) cells were present in the ventral region of the 
developing spinal cord from E 8.5 to E15.5 (Fig. 3.1 and 3.2). At E8.5 only one or two β-gal+ 
cells could be detected per section, and they were mainly located laterally in the spinal cord 
(Fig. 3.1). β-gal expressing cells were found in more rostral region, while in the caudal region of 
the spinal cord no β-gal positive cells were detected. These results suggested that Fgf10 
expression started at E8.5 in the rostral region of the spinal cord.  
At E9.5, β-gal+ cells were detected at all the levels of the spinal cord (Fig. 3.1). There 
were more β-gal+ cells than at E8.5, and organized in “bands” and restricted to the ventral 
region of the spinal cord. Consistent with β-gal expression pattern at E8.5, in the caudal part of 
the spinal cord there were less cells detected per section, than in the rostral part. These findings 
are consistant with downward displacement of cells in normal spinal cord development. 
Neurogenesis begins rostrally in the spinal cord and rostral part is more mature than caudal 
(Nornes and Carry, 1978). 
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Fig. 3.1. Transverse sections of the spinal cord of E8.5 and E9.5 Fgf10-LacZ embryos 
treated with X-gal solution. X-gal is converted into a blue precipitate in the presence of an 
enzyme β-gal, encoded by LacZ gene. β-gal is a reporter of Fgf10 expression. At E8.5 (A – D`) 
there are a few β-gal positive cells (blue) per section, located laterally in the rostral region of the 
spinal cord. At E9.5 (E - H`) the number of β-gal positive cells increases and they can be 
detected throughout the whole spinal cord. Scale bars: (A-D; E-H) 100 µm; (A`-D`; E`-H`) 50 
µm.  
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At E12.5, β-gal expression appeared to be present throughout the whole spinal cord, as 
at E9.5. However, at this stage β-gal+ cells were found clustered in the ventral horns of the 
spinal cord (Fig. 3.2).  
At E14.5, β-gal expression pattern in the spinal cord changed, compared to E12.5 (Fig. 
3.2). β-gal+ cells were still located in the ventral horns of the spinal cord at more rostral regions, 
but also, new zones of β-gal expressing cells emerged in the dorsal region of the spinal cord, on 
either side of the ventricular zone. By E14.5 β-gal expression was discontinued in the caudal 
region of the spinal cord. 
At E15.5, β-gal expression pattern was very similar to E14.5 (Fig. 3.2). 
Knowing that β-gal is a reliable reporter of Fgf10 expression, these results suggested 
that Fgf10 expression started at E8.5 in the rostral region of the spinal cord, continued during 
E9.5 to 14.5 throughout the whole spinal cord in the ventral horns and expired from the caudal 
part of the spinal cord by E14.5. At least from E14.5 new zones of Fgf10 expression emerged in 
more rostral part in the dorsal region of the spinal cord close to the ventricular zone.  
Pattern of β-gal expression in the developing spinal cord of Fgf10-LacZ mice has been 
summarized in a schematic diagram (Fig. 3.3). Timing of β-gal and, therefore, Fgf10 expression 
appeared to correlate with the period of neurogenesis in the spinal cord and its expression 
pattern resembled the location of motor neuron bodies during spinal cord development. 
Consequently, the next step was to determine the exact phenotype of Fgf10 expressing cells or 
their descendants in the developing spinal cord. 
 
 
Figure  3.3. Schematic diagram of β-gal expression in the developing spinal cord of Fgf10-
LacZ reporter mouse from E8.5 to E15.5. At E8.5 β-gal is expressed in the rostral region of 
the spinal cord. At E9.5 to E12 β-gal is present throughout the whole spinal cord. At E 14.5 and 
E15.5 β-gal expression is present rostrally. Please, note, that β-gal is expressed in the ventral 
region of the spinal cord, unless otherwise noted. Asterics (*) indicates that β-gal is expressed in 
the ventral and dorsal regions of the spinal cord. 
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Fig. 3.2. Transverse sections of the spinal cord of E12.5, E14.5 and E15.5 Fgf10-LacZ 
embryos treated with X-gal solution. X-gal is converted into a blue precipitate in the presence 
of an enzyme β-gal, encoded by LacZ gene. β-gal is a reporter of Fgf10 expression. At E12.5 (A 
– D`) β-gal positive cells (blue) are present throughout the whole spinal cord and are located in 
the ventral horns. At E14.5 (E – H`) β-gal expression expires from caudal region, while in  the 
rostral region it is present in the ventral horns and a new area of β-gal expression emerges in 
dorsal part of the spinal cord on either side, close to the ventricular zone. At E15.5 (I – L`) 
pattern of β-gal expression is very similar to the one at E14.5. Scale bars: (E-H; I-L) 200 µm; 
(A-D; E`-H`; I`-L`) 100 µm; (A`-D`) 50 µm.  
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3.2 Fgf10 is expressed by a subset of spinal motor neurons from the 
early stage of their differentiation 
 
3.2.1. Rb-anti-β-gal provides specific staining in the developing spinal cord of 
Fgf10-LacZ mice 
In order to determine what cell types express β-gal, I investigated potential 
colocalization of anti-β-galactosidase antibody (anti-β-gal) with various neuronal markers using 
double-immunostaining technique. Double-immunostaining requires that primary antibodies are 
raised in different species. Given that primary antibodies against neuronal markers, we were 
interested in, were raised in rabbit (Lhx3) and in mouse (NeuN and Islet1, TuJ1), both anti-β-gal 
antibodies (rabbit-anti-β-gal and mouse-anti-β-gal) were needed to examine potential 
coexpression of β-gal with each neuronal marker. 
First, sections of the spinal cord at E9.5 were immunostained with different anti-β-gal 
antibodies to show that β-gal could be detected by immunohistochemistry. Embryos were 
isolated from Fgf10-lacZ mouse, genotyped for the presence of LacZ gene and then LacZ 
positive embryos were sectioned in a transverse plane. Sections of a brain derived from LacZ 
positive adult mouse were used as a positive control (K+) for the tissue, because it was shown 
previously to contain areas of β-gal expression, e.g. in hypothalamus and hipoccampus 
(Hajihosseini et al., 2008). Spinal cord and brain sections were then immunostained with anti-β-
gal, raised in rabbit or in mouse, and imaged on Zeiss Axioimager M2 microscope with an 
Apotome attachment.  
Immunostaining with rabbit-anti-β-gal (rb-anti-β-gal) provided specific staining both in 
the K+ and in the spinal cord sections, while none of mouse-anti-β-gal (ms-anti-β-gal) 
antibodies worked. Four ms-anti-β-gal antibodies (Abcam, Sigma, Cell Signalling and 
Developmental Studies Hybridoma Bank) were used under different conditions and in various 
concentrations, but all of them failed to provide any staining.  
The pattern of β-gal expression at E9.5 provided by immunostaining was consistent 
with the one detected in tissue treated with X-gal, although, in immunostained sections there 
were less β-gal expressing cells per section compared to X-galled tissue  (Fig 3.1 and 3.4). This 
could be explained by the fact that β-gal expressing cells are lying on different levels within the 
section and it was not possible to image all β-gal+ cells at once in immunostained tissue, 
because some would be out of the plane of focus.  Thus, X-gal solution could be more sensitive, 
than anti-β-gal antibody. 
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Fig. 3.4. Transverse sections of the spinal cord of E9.5 Fgf10-LacZ embryo immunostained 
with rb- anti-β-gal antibody. β-gal (green) is a reporter of Fgf10 expression. β-gal positive 
cells can be detected throughout the whole spinal cord. The pattern of β-gal expression detected 
by immunostaining is consistent with the one detected by X-gal solution. Scale bars: (A-D) 100 
µm; (A`-D`) 50 µm. 
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These results suggested that rb-anti-β-gal antibody provided specific staining and could 
be used in double-immunostaining in combination with antibodies raised in mouse, while ms-
anti-β-gal antibodies could not be employed in this study. In order to investigate potential 
coexpression of β-gal with those neuronal markers, antibodies against which were raised in 
rabbit, staining with Horse Radish Peroxidase (HRP) was employed. X-gal stained tissue was 
immunostained with relevant primary antibody and then with secondary HRP antibody, the 
colour was developed using DAB staining solution.  
 
3.2.2. Motor neuron and oligodendrocyte progenitors do not express Fgf10 in the 
developing mouse spinal cord 
Previously, it was shown that β-gal expression in the spinal cord starts at the beginning 
of neurogenesis at E9.5. To see if β-gal is expressed in the ventricular zone cells (VZ cells), 
sections of LacZ positive embryos aged E9.5 were immunostained with rb-anti- β-gal and rb-
Olig2 antibody. At E9.5 Olig2 is a marker of both motor neuron and oligodendrocyte 
progenitors; oligodendrocytes are generated later at E12.5-13. 
As β-gal and Olig2 (rb-Olig2) antibodies were both raised in rabbit and could not be 
used together for double-immunostaining, adjacent sections were immunostained with each 
antibody separately (Fig. 3.5). Analysis showed that β-gal expressing cells lie within the domain 
of MN/OL progenitors and possibly coexpress Olig2.  
To see if it was the case, sections of X-gal stained embryos at E9.5 were stained with 
rb-Olig2 and HRP secondary antibody, and colour was then developed using DAB staining 
solution (Fig. 3.6). Sections were imaged using upright microscope with DIC filter. Consistently 
with previous results, β-gal+ cells lay within the Olig2 domain, however, they did not appear to 
coexpress Olig2.  In more rostral region of the spinal cord the number of β-gal+ cells increased, 
and more of them were lying out of Olig2 domain. 
These results suggested that Fgf10 was not expressed in motor neuron and 
oligodendrocyte progenitors.  
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Fig. 3.5. Transverse sections of the spinal cord of E9.5 Fgf10-LacZ embryo immunostained 
with rb-anti- β-gal (A) and rb-Olig2 (B) antibodies. β-gal (green) is a reporter of Fgf10 
expression, while Olig2 (red) marks motor neuron and oligodendrocyte progenitors. Domain of 
β-gal positive cells appears to correlate with the domain of motor neuron and oligodendrocyte 
progenitors. Scale bars: (A, B) 50 µm.  
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Fig. 3.6. Transverse sections of the spinal cord of X-galled E9.5 Fgf10-lacZ embryo stained 
with rb-Olig2 and Horseradish Peroxidase. β-gal (blue) converts X-gal to a product of blue 
color, and is a reporter of Fgf10 expression. Olig2 marks motor neuron and oligodendrocyte 
progenitors. β-gal positive cells lie within Olig2 domain, although β-gal expression does not 
colocalize with Olig2 expression. In more rostral sections more β-gal positive cells lie out of 
Olig2 domain. Scale bars: (A-D) 50 µm; (A`-D`) 25 µm.  
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3.2.3. A subset of differentiated neurons expresses Fgf10 in the developing mouse 
spinal cord 
As β-gal expression appeared to be absent from VZ cells, but still was located very 
close to the progenitor domain, there was a high possibility that it would be expressed in 
differentiating neurons. 
To see if β-gal was expressed in neurons, double-immunostaining was performed using 
rb-anti-β-gal antibody and TuJ1 (Neuron-specific class III β-tubulin) antibody raised in mouse 
(ms-TuJ1), that is expressed in neurons in CNS and PNS from the early stage of neural 
differentiation and onwards.  Transverse sections of E9.5 LacZ positive embryos were double-
immunostained and imaged using Zeiss Axioimager M2 microscope with an Apotome 
attachment. It was shown that all β-gal+ cells expressed TuJ1 (Fig. 3.7). 
However, immunostaining with TuJ1 antibody did not allow to distinguish between 
early born neurons and more mature ones. In order to understand if Fgf10 was expressed in 
postmitotic neurons, NeuN antibody raised in mouse (ms-NeuN), a marker of postmitotic 
neurons, was used in double-immunostaining in combination with rb-anti-β-gal. 
According to the literature, all neurons migrate out of the ventricular zone when they 
exit their cell cycle (Wolpert et al., 2007).  However, not all the neurons outside ventricular 
zone were positive for a marker of postmitotic neurons, i.e. NeuN. That suggests that NeuN is 
expressed in more mature neurons, and those which lack NeuN expression are in the early stage 
of differentiation. It was shown that β-gal expression colocalized with a subset of NeuN 
expressing cells, although there were β-gal expressing cells that did not express NeuN (fig. 3.8). 
β-gal expression and, therefore, Fgf10 expression, was detected in a subset of neurons 
at the early stage of differentiation, as well as in a subset of postmitotic neurons. However, one 
would have to take into consideration that anti-β-gal antibody could be labelling Fgf10+ cells 
and/or their descendants. 
45 
 
E9
.
5
β-gal/ TuJ1
A
B
B
C
C D D
E
E
 
Fig. 3.7. Transverse sections of the spinal cord of E9.5 Fgf10-LacZ embryo immunostained 
with rb-anti- β-gal and anti- ms-TuJ1. β-gal (green) is a reporter of Fgf10 expression and 
TuJ1(red) marks neurons from the early stage of their differentiation and onwards. β-gal 
expression colocolizes with TuJ1 expression. Scale bars: (A) 100 µm; (B) 50 µm; (C) 25 µm; 
(D, E) 10 µm.  
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Fig. 3.8. Transverse sections of the spinal cord of E12 Fgf10-LacZ embryo immunostained 
with rb-anti- β-gal and anti- ms-NeuN. β-gal (green) is a reporter of Fgf10 expression and 
NeuN(red) marks postmitotic neurons. A subset of NeuN positive cells express β-gal. Scale 
bars: (A) 100 µm; (B) 50 µm; (C, D, E) 10 µm.  
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3.2.4. A subset of motor neurons expresses Fgf10 in the developing mouse spinal 
cord 
Fgf10 was shown to be expressed by differentiated neurons and the pattern of its 
expression, as discussed previously, “mimicked” the location of motor neurons in the spinal 
cord. To see if Fgf10 was expressed in motor neurons, double-immunostaining was performed 
using rb-anti-β-gal antibody and motor neuron markers Islet1 and Lhx3. Islet1 is a LIM-
homeodomain protein initially expressed in all motor neurons immediately after they exit the 
mitotic cycle, but later it is restricted to specific motor neuron subtypes (MMC, HMC, PGC and 
LMCm), while Lhx3 is a marker of MMC neurons and V2 interneurons. 
Initially, staining with anti-Islet1 antibody raised in mouse (ms-Islet1) was perfomed on 
sections of LacZ positive embryos aged E9.5, while sections of older embryos (E12) were used 
as a K+. Ms-Islet1 provided specific staining in the spinal cord at E12, however no specific 
staining was detected in sections of embryos aged E9.5 (data not shown). The reason could be 
that it was too early for Islet1 to be expressed at E9.5, yet. Consequently, sections of E12 
embryos were used for immunostaining with motor neuron markers. 
Double-immunostaining with rb-anti-β-gal and ms-Islet1 was performed on sections of 
LacZ positive embryos and imaged. It was found that some, but not all β-gal+ cells coexpressed 
Islet 1 (Fig. 3.9).  
These results showed that Fgf10 was expressed by a subset of motor neurons that 
expressed Islet1, i.e. all neuronal subtypes except LMCl. 
 Lhx3 antibody was raised in rabbit (rb-Lhx3), hence staining with HRP on X-galed 
embryonic tissue was employed. Sections of E12 embryos treated with X-gal were stained with 
rb-Lhx3 and HRP secondary antibody, and colour was then developed by DAB staining 
solution.  Sections were imaged using an upright microscope with DIC filter. β-gal+ cells were 
mainly located in the ventral horns of the spinal cord, where MMC neurons normally reside. 
Some, but not all β-gal+ cells coexpressed Lhx3 (Fig. 3.10).  
Acquired results suggested that Fgf10 was expressed by a subset of MMC neurons. 
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Fig. 3.9. Transverse sections of the spinal cord of E12 Fgf10-LacZ embryo immunostained 
with rb-anti- β-gal and anti- ms-Islet1. β-gal (green) is a reporter of Fgf10 expression and 
Islet1(red) marks all motor neurons, except LMCl neurons. A subset of Islet1 positive cells 
express β-gal. Scale bars: (A) 100 µm; (B) 50 µm; (C, D, E) 25 µm; (F) 5 µm.  
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Fig. 3.10. Transverse sections of the spinal cord of X-gal stained E12 Fgf10-LacZ embryo 
stained with rb-Lhx3 and Horseradish Peroxidase. β-gal (blue)converts X-gal into a product 
of blue colour and is a reporter of Fgf10 expression. Lhx3 marks neurons of medial motor 
column and V2 interneurons. A subset of Lhx3 positive cells express β-gal. Scale bars: (A) 100 
µm; (B) 50 µm; (C) 10 µm.  
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3.3. Functional analysis of Fgf10 in the developing spinal cord of Fgf10 
knockout mice  
Fgf10 was shown to be expressed in spinal motor neurons during neurogenesis. 
Therefore, it might have a role in motor neuron development, which includes MN migration, 
differentiation into particular subtypes, segregation into motor columns, axon projections, 
synapsing and MN survival during cell death.  
To investigate the role of Fgf10 in the development of spinal motor neurons, Fgf10 
knockout mice were used (Min et al., 1998). The genome of Fgf10 knockouts contains a PGK-
neo cassette inserted into the region of the first exon of Fgf10 that encodes the transcription 
initiation site and the putative signal peptide. This results in disruption of the translation 
initiation codon (ATG), thus, no functional Fgf10 protein being produced. Homozygous Fgf10 
knockout mouse embryos (Fgf10 -/-) are smaller than wild type, do not develop limbs, and die at 
birth due to the absence of lungs (Fig. 2.3). 
Fgf10 knockout and wild type embryos were sectioned in a transverse plane, 
comparable sections of the same level were then chosen (based on spinal cord and ventricular 
shape), immunostained and imaged. Sections of Fgf10 knockout and wild type embryos at 
E10.5 and E14.5 were immunostained with various neuronal and glial markers e.g. Lhx3, NeuN, 
Islet1, Olig2, and compared to elucidate potential variation between them.  
 
3.3.1. Loss of Fgf10 does not appear to affect spinal motor neurons at the 
beginning of neurogenesis 
Fgf10 expression was shown to begin at E8.5, hence, to see if Fgf10 played a crucial 
role in the beginning of neurogenesis, immunostaining was performed on embryos aged E10.5. 
Sections of Fgf10 knockout and wild type embryos were immunostained with ms-NeuN in order 
to see potential differences in number or location of postmitotic neurons, as well as with rb-
Lhx3 to see if there were any differences in MMC neurons and V2 interneurons in particular.  
There were no obvious differences in the pattern of NeuN expression between Fgf10 
knockouts and wild type embryos at E10.5 (Fig. 3.11).  
Lhx3 expression pattern in Fgf10 knockout and wild type embryos was very similar. On 
gross examination it seemed that in Fgf10 knockouts there were more Lhx3 positive (Lhx3+) 
cells than in wild type. Lhx3+ cells were counted in 8 representative sections and numbers were 
compared between sections of the same level in wild type and Fgf10 knockout embryos (Table 
3.1). However, it appeared that the number of Lhx3+ cells per section did not differ 
significantly in the comparable sections of wild type and Fgf10 knockout embryos (Fig. 3.12).   
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Fig. 3.11. Transverse sections of the spinal cord of wild type and Fgf10 knockout embryos 
at E10.5 immunostained with ms-NeuN. NeuN marks postmitotic neurons. Loss of Fgf10 
expression does not appear to affect pattern of NeuN expression. Scale bars: (A, B) 100 µm; 
(A`,B`) 50 µm.  
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Fig. 3.12. Transverse sections of the spinal cord of wild type and Fgf10 knockout embryos 
at E10.5 immunostained with rb-Lhx3. Lhx3 marks neurons of medial motor column and V2 
interneurons. Loss of Fgf10 expression does not appear to affect pattern of Lhx3 expression. 
Scale bars: (A, B) 100 µm; (A`,B`) 50 µm.  
50 
 
         Section 
№ 
1 2 3 4 
Wild type 144 150 164 83 
Fgf10 -/- 140 154 166 85 
 
Table 3.1. Amount of Lhx3 positive cells per section in the transverse plane (width 70 µm) 
in wild type and Fgf10 knockout embryos aged E10.5. 
 
Obtained results suggested that at the beginning of neurogenesis loss of Fgf10 
expression did not drastically affect time of neuronal differentiation i.e. timing of NeuN 
expression, the number of MMC neurons and V2 interneurons and migration of neurons. 
 
3.3.2. Loss of Fgf10 expression does not appear to affect motor neuron and 
oligodendrocyte progenitors at the beginning of neurogenesis 
Fgf10 is a signalling molecule and at E9.5 it was shown to be expressed in cells lying 
within or very close to domain of motor neuron and oligodendrocyte progenitors. Consequently, 
it could play a role in the development of neural progenitors. 
To see if there was any difference in neural progenitor pattern in the spinal cords of 
Fgf10 knockout and wild type embryos, comparable  sections of Fgf10-/- and wild type 
embryos aged E10.5 were immunostained with Olig2, a marker of motor neuron and 
oligodendrocyte progenitors. The pattern of Olig2 positive (Olig2+) cells appeared to be similar 
in Fgf10 knockout and wild type embryos (Fig. 3.13). Olig2+ cells were counted in four 
representative sections and the number of Olig2+ cells in Fgf10 knockouts was very close to 
their number in wild type (Table 3.2).  
 
         Section № 
Genotype          
1 2 
Wild type 34 33 
Fgf10 -/- 35 33 
 
Table 3.2. Amount of Olig2 positive cells per section in the transverse plane (width 70 µm) 
in wild type and Fgf10 knockout embryos aged E10.5. 
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Fig. 3.13. Transverse sections of the spinal cord of wild type and Fgf10 knockout embryos 
at E10.5 immunostained with rb-Olig2 and counterstained with Hoechst. Olig2 (green) 
marks motor neuron and oligodendrocyte progenitors; Hoechst marks cell nuclei. Loss of Fgf10 
expression does not appear to affect number and pattern of Olig2 + cells. Scale bars: (A, B) 100 
µm; (A`,B`) 50 µm.  
 
Achieved results suggested that Fgf10 expression was not necessary for regulating the 
number and position of motor neuron and oligodendrocyte progenitor cells at the beginning of 
neurogenesis.

3.3.3. Loss of Fgf10 does not appear to affect oligodendrocytes and spinal 
motor neurons at the end of neurogenesis 
Fgf10 loss did not appear to affect MMC neurons and V2 interneurons, as well as 
MN/OL progenitors at the beginning of neurogenesis. However, according to β–gal expression 
detected in the developing mouse spinal cord from E8.5 to E15.5, it might be too early for the 
consequences of Fgf10 loss to become obvious at E10.5. Hence, Fgf10 knockout and wild type 
spinal cord sections were compared at E14.5, when β–gal expression disappears from the caudal 
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region of the spinal cord. By that time, normally most of spinal motor neurons are born and 
segregated into motor columns. 
Comparable transverse sections of Fgf10 knockouts and wild type embryos were 
immunostained with various neuronal (NeuN, Islet1, Lhx3) and glial cell (Olig2) markers. Olig2 
at this stage is a marker of oligodendrocytes progenitors and precursors. 
The expression patterns of NeuN, Islet1 and Olig2 in the spinal cord of Fgf10 knockout 
were similar to wild type and no major differences could be detected (Fig. 3.14).  
However, there seemed to be a difference in Lhx3 expression pattern (Fig. 3.15). In 
Fgf10 knockouts, the number of Lhx3+ cells located in the ventral horns of the spinal cord and 
making up medial motor column seemed to be higher, than in wild type. Cell counting showed 
that the number of Lhx3+ cells in the ventral horns per 50 µm was the same in wild type and in 
Fgf10 knockout embryos (Table 3.3). Although, the number of neurons turned out to be the 
same, Lhx3+ motor neurons appeared to be more dispersed in Fgf10 knockouts. This could have 
been a reason for assumption that there were more of them in Fgf10 knockouts, than in wild 
type. 
 
Section № 
Genotype 
1 2 3 4 
Wild type 23 18 16 13 
Fgf10 -/- 21 20 16 12 
 
Table 3.3. Amount of Lhx3 positive cells per section in the transverse plane (width 50 µm) 
in wild type and Fgf10 knockout embryos aged E14.5. Please note that not all Lhx3+ cells 
were counted per section, but only Lhx3+ cells clustered in a column in one of the ventral horns 
of the spinal cord. 
 
Obtained results suggested that Fgf10 loss did not affect generation and maturation of 
Lhx3+ neurons in the spinal cord, as there was no obvious difference between NeuN expression 
patterns in Fgf10 knockout and wild type embryos. Oligodendrocyte generation and distribution 
did not seem to be affected by Fgf10`s absence, either. Fgf10 loss did not appear to affect 
process of motor neuron segregation into distinct motor columns according to their subtype, 
however, MMC neurons seemed to be more dispersed in Fgf10 knockouts.  
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Fig. 3.14. Transverse sections of the spinal cord of wild type and Fgf10 knockout embryos 
at E14.5. Sections were immunostained with various neuronal and glial markers: ms-NeuN, a 
marker postmitotic neurons (A and A`) ; ms-Islet1, that marks marks all motor neurons, except 
LMCl neurons (B and B`); rb-Olig2, a marker of motor neuron and oligodendrocyte progenitors 
(C and C`); All sections were counterstained with Hoechst, staining specific for cell nuclei. Loss 
of Fgf10 expression does not appear to affect expression pattern of postmitotic neurons, Islet1+ 
MN and oligodendrocytes. Scale bars: (A-C`) 100 µm.  
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Fig. 3.15. Transverse sections of the spinal cord of wild type and Fgf10 knockout embryos 
at E14.5 immunostained with rb-Lhx3 and counterstained with Hoechst. Lhx3 is a marker 
of medial motor column (MMC) neurons and V2 interneurons. Hoechst is a dye, specific for 
cell nuclei. Absence of Fgf10 expression does not appear to affect number of MMC neurons, 
however in Fgf10 knockout embryos MMC neurons appear to form more dispersed columns 
than in wild type. White arrowheads point at MMC. Scale bars: (A-D`) 100 µm.  
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3.3.4. In Fgf10 knockout mice axons of motor neurons are misrouted 
Previous results showed that the absence of Fgf10 expression did not affect the number 
of motor neuron and oligodendrocyte progenitors, generation and migration of motor neurons, 
as well as MN differentiation and segregation into distinct motor columns.  The next step was to 
see if Fgf10 was involved in axonal outgrowth and synapse formation.  
Fgf10 knockout and wild type embryos at E10.5 were sectioned in a transverse plane 
and immunostained with cytoplasmic TuJ1 antibody, which marks neuronal bodies and their 
processes from the early stage of neuronal differentiation and onwards. Sections of wild type 
and Fgf10 knockout embryos were lined up according to the spinal cord and its lumen shape to 
make sure they were compared at the same level. 
It was shown that in Fgf10 knockouts at brachial level, where normally limbs develop, 
axons of LMC neurons failed to branch into LMCl and LMCm divisions and formed a cluster of 
misrouted axons (Fig. 3.16).  
These results could suggest that Fgf10 plays role in LMC branching into divisions, 
although, LMC axons could be misrouted, due to absence of their innervation target, as Fgf10 
knockout mice do not have limbs.  
At thoracic level, axons of MMC, HMC and PGC neurons were present and project 
precisely to their targets, dermomyotome, body wall muscles and sympathetic ganglia 
respectively. However, in the Fgf10 knockouts MMC axonal terminals appeared to be 
disordered and in some sections even formed distinct branches (Fig. 3.17).  
Obtained results could suggest that Fgf10 plays a role in LMC branching and synapse 
formation between MMC and dermomyotome, although more Fgf10 knockout embryos have to 
be studied (Table 2.1). 
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Fig. 3.16. Transverse sections of the spinal cord of wild type and Fgf10 knockout embryos 
at E10.5 immunostained with ms-TuJ1 and counterstained with Hoechst. TuJ1 (red) marks 
neurons from the early stage of their differentiation and onwards. Hoechst is cell nuclei specific 
dye. In Fgf10 knockout embryos, LMC neurons, that normally innervate limbs, fail to branch 
into LMCm and LMCl divisions. dm- dermomyotome; dlb-dorsal limb bud; vlb –ventral limb 
bud; MMC-medial motor column; LMCl- Lateral devision of lateral motor column; LMCm –
medial devision of lateral motor column. Scale bars: (A-B`, D, D`) 500 µm; (C, C`, E, E`) 100 
µm.  
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Fig. 3.17. Transverse sections of the spinal cord of wild type and Fgf10 knockout embryos 
at E10.5 immunostained with ms-TuJ1 and counterstained with Hoechst. TuJ1(red) marks 
neurons from the early stage of their differentiation and onwards. Hoechst is a dye specific for 
cell nuclei. In Fgf10 knockout embryos, all subtypes of motor neurons present at thoracic level 
are able to project axons to their targets, i.e. MMC projects to dermomyotome; HPC to body 
wall muscles; PGC to sympathetic ganglia; However, in some sections of Fgf10 knockout 
embryos MMC neurons appear to branch and axonal terminals seem to be disordered. dm- 
dermomyotome; sg-sympathetic ganglia; bw- body wall muscles; MMC-medial motor column; 
HMC-hypaxial motor column.  Scale bars: (A) 500 µm; (B) 250 µm; (C-D`) 100 µm.  
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3.4.  Development of neurons and progenitors cells appear not to be 
affected in FgfR2-IIIc+/∆ mice 
 
FgfR2-IIIc+/∆ mice were used to investigate Fgf10 signalling in the developing mouse 
spinal cord (Hajihosseini et al., 2001). These transgenic mice lack one copy of FgfR2-IIIc that 
results in a gain-of-function mutation due to a splicing switch within FgfR2-IIIc deficient allele. 
In FgfR2-IIIc+/∆ mice, Fgfr2-IIIb isoform is illegitimately expressed along with Fgfr2-IIIc at the 
sites, where normally only FgfR2-IIIc is present. That makes the relevant tissues responsive to a 
broader range of Fgfs than they would normally respond to. FgfR2-IIIc+/∆ mice show Apert 
syndrome-like phenotype that includes defects in the development of several visceral organs and 
bones (Hajihosseini et al., 2009). 
It was hypothesised that if Fgf10 was expressed in the somas, then some abnormalities 
in the development of FgfR2-IIIc+/∆ mouse spinal cord were likely to be seen, due to the 
upregulation of FgfR2IIIb isoform in neural tissues, which is otherwise absent (M. K. 
Hajihosseini personal comments). 
Embryos aged E12.5 were isolated, genotyped, and wild type and FgfR2-IIIc+/∆ 
embryos were then sectioned in a transverse plane. Sections of the spinal cord were 
immunostained with various neuronal markers, e.g. NeuN, marker for postmitotic neurons; 
Olig2, marker for motor neuron and oligodendrocyte progenitors; Lhx3, marker for MMC 
neurons and V2 interneurons. 
Patterns of NeuN, Olig2 and Lhx3 expression in the spinal cord were very similar in 
wild type and FgfR2-IIIc+/∆ embryos (Fig. 3.18). That suggests that the timing of neuronal 
maturation, generation of MN/OL progenitors and specification of neurons into MMC neurons 
and V2 neurons was not affected in FgfR2-IIIc+/∆ mice. 
Obtained results suggest that in the developing mouse spinal cord, Fgf10 is either 
transported to neuronal axons or is expressed in the somas and acts in receptor independent 
manner. 
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Fig. 3.18. Transverse sections of the spinal cord of wild type and FgfR2-IIIc +/∆ mouse 
embryos at E12.5. Sections were immunostained with ms-NeuN, a marker for postmitotic 
neurons (A and A`); rb-Olig2, a marker for motor neuron and oligodendrocyte progenitors (B 
and B`); rb-Lhx3 a marker for MMC motor neurons and V2 interneurons (C and C`). All 
sections were counterstained with Hoechst, cell nuclei specific dye. No difference in expression 
pattern of NeuN, Olig2 and Lhx3 could be detected between wild type and FgfR2-IIIc +/∆ 
mouse embryo at E12.5. Scale bars: (A-C`) 100 µm.  
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4. DISCUSSION 
 
Fgf10 has already been shown to be a multitasking molecule that is of high importance 
for the normal development of the mouse organism. It plays key roles in limb and lung 
development, as well as it is very important for the normal development of heart, pancreas, 
intestine and brain (Bhushan et al., 2001; Kelly et al., 2001; Min et al., 1998; Nyeng et al., 
2011; Sahara and O'Leary, 2009). Fgf10 expression has, also, been detected in the spinal cord of 
4 and 56 days old mice (Allen Institute for Brain Science database).  However, at present, 
nothing is known about its role in the development of the spinal cord. Fgf10 expression has 
been detected recently by in situ hybridization in the spinal cord of E12.5 mouse embryo, 
suggesting it does play a role in development. Based on that knowledge, a research project was 
set up to investigate timing and pattern of Fgf10 expression and its potential role in the 
development of mouse spinal cord.  
 
4.1. β-gal as a reporter of Fgf10 expression in Fgf10-LacZ mice 
Currently, commercial anti-Fgf10 antibodies do not provide any staining. Hence, to 
examine Fgf10 expression pattern in the developing mouse spinal cord Fgf10-LacZ reporter 
mice have been used. This transgenic mouse line carries a nuclear targeted LacZ transgene 
insertion downstream of Fgf10 promoter. Hence, the product of the transgene, enzyme β-gal, 
functions as a reporter of Fgf10 expression and is present in cells expressing Fgf10 and their 
descendants (Hajihosseini et al., 2008; Kelly et al., 2001). β-gal is expressed in the cell nucleus 
and can be detected either enzymatically by a substrate X-gal, which is converted into a blue 
precipitate by β-gal, or by immunostaining with an anti-β-gal antibody. Rb-anti-β-gal antibody 
(Millipore) has been shown to provide specific staining in the developing mouse spinal cord and 
can be used to detect β-gal by immunohistochemitry (Hajihosseini et al., 2008 and our 
unpublished data).  
It is necessary to remember that β-gal expression in Fgf10-LacZ mice is nuclear, while 
Fgf10 molecule could be localized anywhere in the cell, including axons and its terminals, 
where from it might be secreted later.  
In the developing mouse spinal cord, β-gal expressing cells were detected from E8.5 to 
E15.5, although, it is not known how stable β-gal is and there is a possibility that product of 
LacZ gene may be detected after Fgf10 stops being expressed. Therefore, β-gal expression may 
not accurately reflect the timing of Fgf10 mRNA expression.  
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It is possible to tackle this problem either by doing a series of in situ hybridizations for 
Fgf10 at various stages of embryonic development, or by using tamoxifen inducible Fgf10CreERT2 
:: ROSA26 LacZ mouse line (S. Bellusci and M.K. Hajihosseini personal communication).  In 
this transgenic mouse line cytoplasmic expression of LacZ gene is induced in Fgf10 expressing 
cells by tamoxifen. In contrast to Fgf10-LacZ mice, in Fgf10CreERT2 :: ROSA26 LacZ mice, LacZ 
expression is not discontinued when Fgf10 stops being expressed. That allows to induce LacZ 
expression in Fgf10CreERT2 :: ROSA26 LacZ mice at certain stages of pregnancy, then sacrifice 
mice and X-gal embryos in order to see if LacZ was expressed at the relevant developmental 
stage. 
β-gal can be detected not only in cells that express or used to express Fgf10, but also, in 
their descendants. However, in the developing spinal cord, β-gal was detected in neurons, but 
not in their progenitor cells. According to the literature, neurons do not divide anymore after 
they migrate out of the ventricular zone (Wolpert et al., 2007). Therefore, it seems very unlikely 
to detect β-gal expression in descendants of Fgf10 expressing cells in the spinal cord. 
 
4.2. Pattern of Fgf10 expression in the developing mouse spinal cord 
A clear expression of Fgf10 has been observed in the ventral horns of the developing 
mouse spinal cord from E9.5 up to E14.5 (Watson et al., 2008). From at least E14.5, Fgf10 
expression disappears completely from caudal region of the spinal cord, while it is maintained 
rostrally, and new areas of its expression appear symmetrically on either side in the dorsal 
region of the spinal cord. Conversely, studies have shown the presence of Fgf10 expression in 
the spinal cord of juvenile and adult mice, 4 days and 56 days old, respectively (Allen Institute 
for Brain Science database). In the spinal cord of a juvenile mouse Fgf10 expressing cells are 
concentrated in the ventral horns of the spinal cord in the caudal region, while in the spinal cord 
of an adult mouse Fgf10 is expressed along the entire spinal cord and Fgf10 positive cells are 
scattered around the grey matter. These observations indicate that Fgf10 might be expressed in a 
mixed cell population and play diverse roles at different stages of development. 
Fgf10 may be expressed in at least two different cell populations. One of them 
originates at about E14.5 in the dorsal region, rostrally in the spinal cord. As Fgf10 expressing 
cells are located close to ventricular zone it suggests they recently migrated out and are 
differentiating.  It is known that 80% of oligodendrocyte precursors (OLP) are generated at 
E12.5-13 from the MN/OL progenitor domain, located in the ventral region of the spinal cord. 
However, the remaining OLP are produced later at E14.5, from the progenitor domain located in 
the dorsal region (Cai et al., 2005; Li et al., 2011). Also, it has been shown previously, that 
certain Fgfs, e.g. Fgf2, are required for oligodendrocyte generation from the dorsal domain of 
progenitors in vitro (Chandran et al., 2003). These facts suggest that Fgf10 expressing cells in 
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the dorsal domain could possibly be newborn oligodendrocytes. Double labelling at this stage 
would help to confirm this relationship. 
This report focused on the other Fgf10 expressing cell population that originates from 
the ventral region at E8.5 and later settles in the ventral horns of the spinal cord. It has been 
noticed that Fgf10 expression in the ventral horns correlated with neurogenesis pattern in the 
spinal cord, and with the time and pattern of motor neuron generation in particular. MN are first 
neurons to be born and they are generated in the ventral region of the spinal cord from E9.5 to 
E13.5, then migrate laterally and settle in the ventral horns of the spinal cord (Watson et al., 
2008). Fgf10 expression in the spinal cord resembled this pattern very much. In addition, first 
neurons are born rostrally and there were more Fgf10 expressing cells in rostral region, which is 
more mature region of the spinal cord, than caudal (Altman and Bayer, 1984).  
Indeed, β-gal has been detected in early differentiated neurons and in motor neurons in 
the developing spinal cord of Fgf10-LacZ mice. It is not known, whether β-gal positive mature 
neurons still express Fgf10, but it is nice to speculate that Fgf10 could be expressed in 
postmitotic cells.  Previously, Fgf10 was mainly reported to be involved in cell proliferation and 
progenitor domain maintenance, e.g. in white adipose tissue and intestine (Konishi et al., 2006; 
Nyeng et al., 2011; Nyeng et al., 2007).  
 
4.3. Potential roles of Fgf10 in the development of mouse spinal cord 
In the developing mouse spinal cord Fgf10 expression has been detected in early 
differentiated neurons and later in motor neurons. The timing of Fgf10 expression in the ventral 
region of the spinal cord correlates with motor neuron birth and maturation. These observations 
suggested Fgf10 has a role in the development of the ventral region of the spinal cord and in 
MN generation and differentiation in particular. Fgf10 could be involved in transition from 
progenitor cells to mature neurons; MN differentiation into particular subtypes; segregation into 
motor columns; axonal outgrowth and/or navigation to subtype specifc targets; synaptogenesis 
or cell death.  
 
4.3.1. Potential role of Fgf10 in MN identity and their transition from progenitor 
cells to motor neurons during neurogenesis in the developing mouse spinal cord 
Initially, Fgf10 expression in the spinal cord is detected in early differentiated neurons, 
which lie in motor neuron and oligodendrocyte progenitor domain. That suggests Fgf10 
expression enables motor neuron progenitors to exit their cell cycle and become early born 
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motor neurons, in such a way regulating identity of motor neurons, as well as timing of their 
generation and their quantity.  
Obtained results show that Fgf10 expression is not necessary for motor neurons to 
become postmitotic and it does not seem to play role in MN identity. In the absence of Fgf10 
expression neurons were able to exit their cell cycle and MMC neurons were generated at the 
same time and quantity as in wild type.   
Also, it was hypothesised that if Fgf10 was involved in motor neuron identity, in the 
spinal cord of Fgf10 knockouts fate switch might take place, i.e. progenitors that were meant to 
become motor neurons, might differentiate into oligodendrocytes that are generated from the 
same progenitors domain. Results show that Fgf10 is unlikely to play role in motor neuron 
identity, because in Fgf10 knockouts at E10.5 and E14.5 amount of MMC neurons and OL 
progenitors and precursors was the same as in wild type. 
 However, not all MN subtypes were visualised and compared during this study and 
there is a possibility that there might be a fate switch in motor neuronal subtypes. To exclude or 
confirm Fgf10 role in motor neuron identity, further research should be performed with all MN 
subtypes included into the study. 
 
4.3.2. Potential role of Fgf10 in MN differentiation into particular subtypes and 
segregation into motor columns 
Fgf10 expression has been detected in differentiating and mature motor neurons that 
suggested its role in motor neuron differentiation and migration to their final positions 
according to their neuronal subtype. Achieved results show that in the absence of Fgf10 
expression motor neurons are able to migrate and to segregate into distinct motor columns.  
Fgf10 expression has not been assigned to any particular MN subtype, but at E12 it was 
mainly detected in MMC neuron domain, which suggests its role in the development of this 
particular type of MN. However, Fgf10 absence did not affect MMC subtype generation and 
migration to the final position medially in the ventral horns.   
Interestingly, at E14.5 MMC neurons in Fgf10 knockouts seemed to be more dispersed 
than in wild type. That suggests Fgf10 role either in timing of MMC neuron migration to their 
final position or organization of MMC neurons into a discrete column. 
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4.3.3. Potential role of Fgf10 in axonal outgrowth and guidance of motor neurons 
to innervation targets according to their subtype 
β-gal faithfully reports Fgf10 expression in a particular cell, however, the site of Fgf10 
localization in the cell can not be detected through β-gal expression. Fgf10 molecule could be 
located and secreted from any part of the motor neuron, including axons. That suggests Fgf10 
role as a guidance molecule and its involvement in the outgrowth of motor axons and their 
projection to specific muscles. Fgfs have been shown previously to play role of 
chemoattractants, e.g. Fgf8 has been shown to attract MMC neurons to the dermomyotome 
(Shirasaki et al., 2006); Fgf10 has been shown to act as a chemoattractant for the lung 
epithelium during development (Park et al., 1998). Fgf10 could play a role of the guiding 
molecule for motor neuron axons.  
Axonal projections of all motor neuron subtypes, except LMC neurons, were able to 
develop, exit ventrally of the spinal cord and project to their target muscles according to their 
subtypes. At the limb level, LMC neurons that innervate limb muscles failed to branch into 
LMCl and LMCm divisions and formed a cluster of disordered axonal terminals. Possible 
explanation could be that Fgf10 knockout embryos do not have limbs and LMC neurons lack 
their innervation target in this mutant.  
These results suggest that Fgf10 is unlikely to have a role in axonal outgrowth and 
guidance to their innervation targets. Further studies using limbless Fgf10 expressing mutant 
mouse as a positive control would be necessary. 
 
4.3.4. Potential role of Fgf10 in synapse formation between terminals of MN axons 
and their target muscles 
In the spinal cord of Fgf10 knockout embryos LMC neurons fail to branch and instead 
form a disordered cluster of axonal terminals. In addition, axonal terminals of MMC neurons 
appear to look disordered and in some sections even branch out. Fgf 22 and its closest relatives 
(Fgf7 and Fgf10) have, already, been implied a role in synapse formation in the mammalian 
brain and it is very likely that Fgf10 may be involved in synaptogenesis in the spinal cord 
(Umemori et al., 2004).  
In addition, Fgf10 expression has been detected in the ventral horns of the spinal cord in 
a juvenile mouse, aged 4 days. Knowing that maturation of a neuromuscular junction takes up to 
3 weeks in rodents, it can be suggested that Fgf10 is involved in synapse maturation postnatally  
as well (Wolpert et al., 2007) 
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Further research on Fgf10 role in synaptogenesis has to be performed in vivo and in 
vitro. For example, coculture primary motor neurons, from embryonic mouse spinal cord, and 
myoblasts, to investigate Fgf10 role in synapse formation in vitro. 
 
4.3.5. Potential role of Fgf10 in motor neuron survival during cell death 
Neuronal death is a natural event occurring about the time when motor neuronal axons 
are reaching their target muscles, and that continues even after synapses have been established, 
until each muscle fiber is innervated by axon terminals from one motor neuron (Wolpert et al., 
2007). As Fgf10 is expressed in a subset of motor neurons during their differentiation that 
includes cell death, it could be involved either in promoting neuronal cell death or play role in 
MN survival.  
It has been shown in chicken, that the number of surviving motor neurons depends on 
the amount of limb musculature, in the absence of the limb bud the amount of motor neurons 
decreased severely (Lanser and Fallon, 1987). As Fgf10 knockout embryos are limbless and, 
therefore, lack targets for axonal projections, it was hypothesised that in Fgf10 knockout 
embryos there should be less motor neurons present due to enhanced cell death, even if Fgf10 is 
not involved in MN survival.  Surprisingly, in limbless mouse embryos the amount of motor 
axons did not seem to be reduced.  
These results could suggest Fgf10 role in promoting cell death, however further studies 
are necessary. Employing another limbless mutant, for example Lef1(-/-)Tcf1(-/-) as a positive 
control, would be an advantage (Galceran et al., 1999). 
 
4.4. Fgf10 signalling in the developing mouse spinal cord 
β-gal is a faithful reporter of Fgf10 expression in Fgf10-LacZ mice. However, it does 
not provide information in which part of the cell Fgf10 is expressed. It could be expressed either 
in the cell bodies located in the grey matter of the spinal cord or in the neuronal axons. FgfR2-
IIIc isoform has been shown to be predominant in the adult CNS, including the spinal cord (Fon 
Tacer et al., 2010). In the developing mouse spinal cord FgfR2 isoform has not been identified, 
but it is known that in the other parts of developing CNS, FgfR2-IIIc isoform is abundant 
(personal communication with M. K. Hajihosseini). Therefore, it has been assumed that in the 
developing mouse spinal cord FgfR2-IIIc isoform is present. If Fgf10, which normally signals 
through FgfR2-IIIb isoform, was expressed in the cell bodies, most probably it would have 
signalled independently of the receptor. 
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To investigate Fgf10 signaling in the developing mouse spinal cord, FgfR2-IIIc+/∆ mice 
were used. These mice, due to a gain-of-function mutation, express both FgfR2 isoforms in 
neural and mesenchymal tissues, where normally only FgfR2-IIIc would be expressed.  
It was predicted that if Fgf10 molecule was secreted in the spinal cord, then there would 
be some differences in neuronal and/or MN/OL progenitor expression pattern in FgfR2-IIIc+/∆ 
mice compared to wild type, because it would activate FgfR2-IIIb  isoform that normally is not 
present.  
FgfR2-IIIc+/∆ mice showed no abnormalities in the spinal cord. This indicates that Fgf10 
is either expressed in motor neuron bodies and functions in receptor-independent manner, or 
transported to the motor neuronal axons or their terminals.  
Further work has to be performed to characterize the way Fgf10 mediates its signalling 
in the spinal cord.  For example, to identify FgfR2 receptor isoform in the developing mouse 
spinal cord through RT-PCR or immunohistochemistry in the wild type and in FgfR2-IIIc+/∆ 
mice. 
4.5. Future directions 
Fgf10`s role still has to be elucidated and it is of high importance to continue research 
about Fgf10 involvement in the development of mouse spinal cord and motor neurons in 
particular. It has already been shown that Fgf10 is expressed during motor neuron 
differentiation and maturation, and may have a key role at one of the stages, for example in 
synapse formation. If its role during normal development will be determined, it potentially can 
further our understanding of the mechanisms of neurodegenerative diseases, such as ALS, and 
promote clinical therapies for patients with spinal cord injuries or suffering from motor neuron 
diseases. In addition, knowing Fgf10 role in normal MN development could provide novel 
insight into stem cell differentiation in vitro into distinct neuronal subtypes. 
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